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V.   ABSTRACT 
 
G-protein-coupled receptors (GPCRs) constitute the largest and most divergent class of cell 
surface proteins. GPCRs can be activated by extracellular signals as diverse as light, peptides, 
proteins, lipids, odorants, tastants, nucleotides and nucleosides. Currently, all the known 
chemosensory receptor genes, such as odorant, taste and pheromone receptors belong to the 
GPCR family, with many of them being class A or class-A related genes. Metabotropic P2Y 
receptors belong to class A GPCRs and are activated by extracellular nucleotides. Nucleotides 
are released to the environment when the organism is injured and therefore serve as one of the 
food stimuli. As such, it would be interesting to see if P2Y receptors play any role in olfaction in 
zebrafish. 
To date, eight functional human P2Y receptors and 25 related orphan receptors have been 
found. I performed extensive data mining in drosophila, ascidian, jawless, cartilaginous and 
bony fish, frog and human genomes to delineate the P2Y family and investigate its evolutionary 
origin. The P2Y family originates early in the vertebrate lineage, reflected by the presence of 
lamprey and the absence of ascidian orthologues. Consistent with these findings, no P2Y 
receptor is found in invertebrates. In total, 38 subfamilies can be distinguished within the P2Y 
family, at least two third of which are already present in the shark genome. Two subfamilies, 
p2yl-3 and p2yl-4, are lost in the human lineage and only GPR 87 subfamily is lost in all teleost 
species.    
Zebrafish has 68 P2Y receptor genes, the most of any fish species, and almost double as many 
than mammals. The teleost P2Y genes are widely distributed in the genome as small cluster 
and singletons. The vast majority of P2Y genes are intronless while the remaining genes 
contain up to five introns. In the teleost lineage, the genomic arrangement of P2Y genes is 
preserved to a large extent, and some synteny is found even with the elephant shark and 
human genome, possibly reflecting the functional importance of these genes. Selective pressure 
on teleost P2Y genes generally is high, as evidenced by a preponderance of negative selection. 
However, a few genes exhibit positive selection at individual sites.   
In early development, P2Y genes are expressed in many tissues and organs, notably the central 
and peripheral nervous system, pharyngeal arches, otic vesicle and kidney, suggesting an 
important role in the development of many tissues. However, no expression is detected in larval 
olfactory epithelium. In contrast, olfactory epithelium of adult fish does express several P2Y 
genes as shown by RT-PCR. A possible explanation would be a late onset of expression in the 
olfactory epithelium. In situ hybridisation of adult olfactory epithelium established an ubiquitous 
distribution, both in the sensory and non-sensory region, which seems to argue against a role of 
P2Y genes in nucleotide odor detection. However, further studies will be necessary to give a 





VI.   ZUSAMMENFASSUNG 
 
Bei den G-protein-gekoppelten Rezeptoren (GPCRs) handelt es sich um die größte und 
vielfältigste Gruppe von Membranproteinen. GPCRs werden durch sehr diverse extrazelluläre 
Signale aktiviert, von Licht über Peptide, Proteine zu Geruchs- und Geschmacksstoffen, bis hin 
zu Lipiden, Nukleotiden und Nukleosiden. Alle gegenwärtig bekannten chemosensorischen 
Rezeptoren, wie die Geruchs-, Geschmacks- und Pheromonrezeptoren gehören der GPCR 
Familie an, und viele davon sind aus der Klasse A der GPCR. Das gilt auch für die 
metabotropen P2Y Rezeptoren, die durch extrazelluläre Nukleotide aktiviert werden. Nukleotide 
werden freigesetzt, wenn ein Organismus verletzt wird, und können so als Signale zur 
Nahrungsdetektion dienen. Es erschien daher interessant, zu untersuchen, ob die von Fischen 
bekannte Geruchsdetektion von Nukleotiden durch P2Y Rezeptoren vermittelt sein könnte.  
Die P2Y Familie im Menschen besteht aus acht funktionalen P2Y Rezeptoren und 25 
verwandten Rezeptoren mit bisher unbekannten Liganden. Ich habe ausführliche 
Datenbanksuchen in Genomen der Taufliege, von Aszidien, Kieferlosen, Knorpelfische und 
Knochenfische, sowie in Frosch und dem menschlichen Genom durchgeführt, um die P2Y 
Familie zu identifizieren und von benachbarten Familien abzugrenzen. Meine Ergebnisse 
zeigen, dass die P2Y Familie in frühen Wirbeltieren entstanden ist, da Vertreter dieser Familie 
im Neunauge, aber nicht in Aszidien vorkommen. Konsistent zu diesen Befunden konnten auch 
keine P2Y Rezeptoren in Wirbellosen gefunden werden. Insgesamt können 38 Unterfamilien 
innerhalb der P2Y Familie unterschieden werden, von denen mindestens 2/3 bereits im 
Haifischgenom vorhanden sind. Zwei Unterfamilien, p2yl-3 und p2yl-4, sind in der menschlichen 
Entwicklungslinie verloren gegangen, eine weitere Unterfamilie, GPR87, ist am Beginn der 
Knochenfischentwicklung verloren gegangen. 
Der Zebrabärbling weist 68 P2Y Gene auf, am meisten von allen Fischarten, und fast doppelt so 
viele wie die Säuger. Die P2Y Gene kommen breit verteilt als kleine Cluster oder Einzelgene im 
Fischgenom vor. Die überwiegende Zahl der P2Y Rezeptorgene hat keine Introns, manche 
jedoch weisen bis zu fünf Introns auf. In der Entwicklungslinie der Knochenfische ist die relative 
genomische Anordnung der P2Y Gene zum großen Teil erhalten, und eine gewisse Syntenie 
läßt sich sogar zu den Genomen von Haifisch und Mensch beobachten. Eine solch hohe 
Konservierung spricht für die funktionale Bedeutung dieser Gene. Der Selektionsdruck auf die 
P2Y Gene der Knochenfische ist hoch, wie aus dem Überwiegen negativer Selektion ersichtlich 
wird. Manche Gene zeigen allerdings positive Selektion an vereinzelten Positionen. 
In der frühen Entwicklung werden P2Y Gene in vielen Geweben und Organen exprimiert, 
insbesondere dem peripheren und zentralen Nervensystem, den Kiemenbögen, dem Ohrvesikel 
und der Niere, konsistent mit einer vielfältigen Rolle dieser Gene in der Entwicklung vieler 
Gewebe. Allerdings liess sich keine Expression im larvalen Riechepithel feststellen. Im 
Gegensatz dazu werden viele P2Y Gene im adulten Riechepithel exprimiert, wie ich sowohl mit 
RT-PCR als auch In situ-Hybridisierung zeigen konnte. Eine mögliche Erklärung dieser 
Diskrepanz wäre ein später Beginn der Expression im Riechepithel. In der In situ-Hybridisierung 
zeigt sich eine breite Expression der P2Y Gene sowohl im sensorischen als auch dem 
nichtsensorischen Bereich des Riechepithels, unerwartet für eine mögliche Funktion der P2Y 
Gene in der Geruchsdetektion von Nukleotiden. Weitere Studien werden erforderlich sein, um 




1.   Introduction 
 
A family of nucleotide receptor in teleost fishes, P2Y, is described in this thesis. As detailed 
below, there is a reason to suggest a possible function as sensory receptors for members of this 
family. This work presented here serve as a basis to investigate this possibility.  
 
1.1   Nucleotides 
Nucleotides are molecules composed of a nitrogen-containing ring compound linked to a five-
carbon sugar and a phosphate group. The sugar involved in the synthesis and structure of a 
nucleotide can be either ribose or deoxyribose, Ribonucleotides are nucleotides containing 
ribose whereas deoxynucleotides are nucleotides containing deoxyribose. The phosphate group 
may consist of up to three phosphates forming monophosphates, diphosphates, or 
triphosphates, respectively. Nucleotide is named after the utilized base, either purine or 
pyrimidine. Purine bases are adenine and guanine whereas pyrimidines are cytosine, thymine 
and uracil.   
 
Nucleotides are essential in the cell. They are the building blocks of the hereditary information. 
Besides that, nucleotides have many other functions in the cell: i) carrier of chemical energy in 
the cell, ii) coenzyme when combine with vitamin or its derivative and iii) signalling molecule in 
the cell. Ribonucleotide adenosine triphosphate, ATP, is used to transfer energy in hundreds of 
different cellular reactions. ATP is synthesized via the addition of a phosphate group to ADP. 
When energy is required, ATP releases its energy through its hydrolysis to ADP and inorganic 
phosphate. The regenerated ADP is reused for subsequent phosphorylation reactions that form 
ATP. Nucleotides bind to vitamin and its derivatives to form coenzyme. Coenzyme involved in 
both group-transfer and redox reactions in metabolism. Cyclic AMP (cAMP) is one of the 
signaling molecules in the cell. cAMP is derived  from ATP by plasma membrane bound enzyme 
adenylnyl cyclase and is involved in intracellular signal transduction in organism.  
 
1.2   Purine and pyrimidine 
Purine consist of a pyrimidine ring (six-membered ring) fused to imidazole ring (five-membered 
ring). Members of purine include adenine, guanine, hypoxanthine, xanthine, theobromine, 
caffeine, uric acid and isoguanine. Purines are involved in many aspects of cellular processes: 
intermediary metabolism, nucleic acid synthesis and the supply of energy phosphates to various 
active transport systems. In cells, ATP is abundantly found as ATP is the main energy-providing 
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and energy-storing molecule for all biological processes. On the other hand, GTP is rarely used 
as an energy donor but rather to transmit signals throughout the cell notably in G-protein 
signaling cascade. In additions, purines appear to be ligand of specific receptor reside within 
plasma membrane which mediate changes in cell function in response to extracellular purines 
(Stone, 1982).  
 
Unlike purine, pyrimidine comprise of six-membered ring. Pyrimidine members include cytosine, 
thymine and uracil. In the cell, pyrimidine serves as energy source for specific metabolic 
reactions. UTP is the source for activating glucose and galactose whereas CTP is an energy 
source in lipid metabolism.  
 
 
1.3   Purine receptor 
Purine receptors are cell surface receptors that transduce extracellular signals to an intracellular 
signal to induce a cellular response. There are two main families of purine receptors, P1 and P2 
receptors. The P is an abbreviation for purinergic. P1 receptor is activated by adenosine 
whereas P2 receptor is activated by nucleotides (Abbracchio et al., 2006). 
 
P1 or adenosine receptor family comprises of A1, A2A, A2B, and A3 adenosine receptors. The 
adenosine receptor family belongs to G- protein coupled receptor (GPCR). All the receptors 
couple to G proteins to activate the signaling cascades.  A1 receptor couples to both Gi/o and 
Gq/11  to activate phospholipase C pathway whereas A1 receptor only couples to Gi/o. On the 
other hand, both A2A and A2B receptors couple to Gs to increase cAMP concentration in the cell 
(Ralevic and Burnstock, 1998). Adenosine receptors are involved in modulation of 
cardiovascular, immune and central nervous systems (Burnstock, 2007). 
 
P2 receptors are divided into two major families, P2X and P2Y. P2X family is of ligand-gated ion 
channel whereas P2Y family belongs to G-protein-coupled receptor (GPCR). P2X family is 
activated by extracellular adenosine 5’-triphosphate (ATP) and seven subunits have been 
identified to date, P2X1-7. All the members possess two transmembrane-spanning regions in 
which N and C termini that have consensus-binding motifs for protein kinases reside 
intracellularly. The first TM is involved in channel gating and the second lining the ion pore 
(Fields and Burnstock, 2006). P2X receptors are homomeric or heteromeric assemblies of three 
subunits (Koles et al., 2008) P2X receptors mediate rapid (onset within 10ms) non-selective 
passage of cations (Na+, K+, Ca2+) across the cell membrane resulting in an increase of Ca2+ 
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and depolarization (Bean, 1992; Dubyak and el-Moatassim, 1993). The direct influx of 
extracellular Ca2+ through the channel constitutes a significant source of the increase in 
intracellular Ca2+. However, membrane depolarization leads to the secondary activation of 
voltage-dependent Ca2+ channels, which probably make the primary contribution to Ca2+ influx 
and to the increase in intracellular Ca2+. Since this transduction mechanism does not depend on 
the production and diffusion of second-messengers within the cytosol or cell membrane, the 
response time is very rapid, and appropriately plays an important role in fast neuronal signaling 
and regulation of muscle contractility (Ralevic and Burnstock, 1998). P2X receptors are 
important in neuronal signaling, pain transmission and inflammation. 
 
1.4   P2Y receptor 
P2Y receptors are cell-surface receptors that belong to G-protein coupled receptor (GPCR) 
superfamily. As such, P2Y receptors share the common molecular architecture of GPCR, 
consisting of seven transmembrane domains connected by three intracellular and three 
extracellular loops. GPCR superfamily composed of five families, namely rhodopsin, secretin, 
adhesion, glutamate and frizzled/taste2. P2Y receptors belong to rhodopsin/Class A family, 
which is the largest family of GPCRs. Rhodopsin family of GPCRs have short N termini and the 
receptors are primarily activated by interactions of ligand with transmembrane regions and 
extracellular loops. This metabotropic receptor form the δ-group together with MAS-related, 
glycoprotein and olfactory receptors in rhodopsin family. P2Y receptors are activated not only by 
ATP, but also naturally occurring nucleotides or nucleotide sugars such as ADP, UTP, UDP and 
UDP glucose (Fredriksson et al., 2003; Abbracchio et al., 2006; Langerstrom and Schioth, 
2008).  
 
1.4.1   Structure 
P2Y family is composed of 8 subtypes that were cloned and functionally defined in human: 
P2Y1, P2Y2, P2Y4, P2Y6, P2Y11, P2Y12, P2Y13 and P2Y14. These receptors are phylogenetically 
divided into 2 subgroups, one encompassing receptors that mainly couple to Gq protein and the 
other to the Gi protein. The subgroup that couple to Gq protein comprised of P2Y1, P2Y2, P2Y4, 
P2Y6 and P2Y11 receptors whereas the second subgroup that couple to Gi comprised P2Y12, 
P2Y13 and P2Y14. Additionally, several other structurally related GPCR such as lipid mediators, 
platelet-activating factor, cysteine leukoriene and orphan receptors are clustered with both 
groups (Constanzi et al., 2004; Schoneberg et al., 2007).  Most of the gene sequences of P2Y 
receptors appear to be intronless with the exception of P2Y11. P2Y11 receptor gene has an 
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intron interrupting the coding sequence after the first six amino acids (Kugelgen and Wetter, 
2000). 
 
P2Y receptors have different selectivity for adenine or uracil nucleotides, 5’-diphosphates and 
5’-triphosphate. P2Y1, P2Y12 and P2Y13 are selective for adenine nucleotides, whereas P2Y4, 
P2Y6 and P2Y14 are selective for uracil nucleotides. P2Y2 and P2Y11 are not selective to both 
uracil and adenine nucleotides. Lastly, P2Y14 has an atypical selectivity for UDP-glucose 
(Costanzi et al., 2004). 
 
P2Y receptors share some motif of Class A GPCRs, ‘DRY’ and ‘D/NPxxY(x)5,6F’ motif at the 
cytoplasmic end of TM3 and TM7 respectively. Additionally, these receptors possessed 
signature motif of their own. All known P2Y receptor subtypes possess 4 cysteine residues at 
their extracellular domains which form 2 disulfide bridges: the first one between N-terminal 
domain and EL3 and the second bridge between EL1 and EL2 (Hoffmann et al., 1999). Besides 
that, consensus sequence ‘S(I/V)(L/I)FLTCIS’ is also conserved in TM3 (Kugelgen and Wetter, 
2000). Although the receptors in P2Y family display a relatively high diversity in amino acid 
composition, conserved residues were found in TM3, 6 and 7 which are involved in ligand 
binding (von Kugelgen, 2005).  
 
1.4.2   Signal transduction 
P2Y1, P2Y2, P2Y4, P2Y6 and P2Y11 receptors couple preferentially to the stimulation of 
phospholipase C (PLC) via Gq, and P2Y12, P2Y13 and P2Y14 receptors couple to the inhibition of 
adenylnyl cyclase via Gi. P2Y11 was also couple to the stimulation of adenylate cyclase via Gs. 
However, the specific downstream signal transduction pathway seems to be depending not only 
on P2Y subtype but also on cell type expressing receptor (Ralevic and Burnstock, 1998). P2Y13 
receptor couple to Gi protein subunits and subsequently inhibits adenylnyl cyclase and cAMP 
formation. However, transfected P2Y13 receptor in 1321N1 neuroblastoma cells and Chinese 
hamster ovary can simultaneously couple to Gi, G16 and also Gs upon stimulation by ADP 
(Marteau et al., 2003). Stimulation of ATP in transfected P2Y11 receptor in 1321N1 
neuroblastoma cells induced an increase in IP3 and cytosolic Ca
2+ as well as cAMP via Gq and 
Gs respectively. Stimulation with UTP unexpectedly increases only cytosolic Ca
2+ suggesting 





Besides that, P2Y receptors also interact with cellular macromolecules, inducing signaling 
cascades that mediate responses in the cell. The interaction of P2Y receptors with small 
homomeric G proteins, integrins and tyrosine kinases activates mitogen-activated protein 
kinases (MAPK), in particularly extracellular signal-regulated kinase (ERK) pathway. In addition, 
P2Y receptors interact with PDZ domain and induce ion channel responses to induce trafficking 
in cellular membrane. The interplay of P2Y receptors with distinct G proteins and signaling 
pathways further indicates the complexity of this receptor family (Fischer and Krugel, 2007; 
Koles et al., 2008). 
 
1.4.3   Biological function 
P2Y receptors are involved in neuronal and non-neuronal mechanisms in regulating 
neurotransmission, secretion, cell division, proliferation, differentiation, regeneration and 
apoptosis in the cell. These receptors are broadly expressed in many tissues notably in the 
central and peripheral nervous system (Table 1). The wide expression of P2Y subtypes in 
central nervous system indicates that these receptors are part of a component to maintain 
physiological balance in neuronal transmission directed to the survival of the organism. P2Y 
receptors mediate food foraging, response to enemies as well as reaction to injury, inflammation 
and oxygen deficiency in the organism (Burnstock, 2006; Fischer and Krugel, 2007).  
 
1.5   Purinergic signaling  
Extracellular purines are released by the cell itself to stimulate the activation of purinergic 
signaling. Purinergic receptor activation subsequently trigger a host of second messenger 
systems and other signaling molecules including cyclic AMP (cAMP), inositol-1, 4, 5-
triphosphate (IP3), phospholipase C (PLC), arachidonic acid and nitric oxide leading to an 
increase of intracellular calcium concentration (Fields and Douglas, 2006). 
 
ATP is an extracellular signaling molecule that exerts potent physiological response on a variety 
of tissues and cell types. ATP is released not only by presynaptic terminal but also postsynaptic 
membrane and other cells. The release occurs not only in response to neurotransmitter 
stimulation but also in response to physiological states to mechanical stress, hypoxia, 
inflammation and agonists. The degradation of ATP in extracellular space by ectoenzymes 
subsequently activates various types of P2X and P2Y receptors to provide a homeostatic 
regulation mechanism in the cell. P2X receptors act within milliseconds because ligand binding 
is directly linked to channel opening. Thus, P2X receptor can mediate fast ATP signaling over 
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short distances. In contrast, P2Y receptors can recognize lower concentrations of nucleotides 
(in the range of nM) and the binding of agonist triggers second messenger pathways. The 
signals and its duration is amplified and prolong over hundreds of milliseconds or even seconds, 
which makes it attractive as a neuromodulatory functions. Once released, ATP is rapidly 
degraded by ectonucleotidases to ADP, an agonist of P2Y1, 12, 13 rceptors. The degradation of 
ADP in turn generates AMP and later adenosine, which stimulates postsynaptic adenosine 
receptors. Adenosine receptors then activates neuronal K+ conductance and may also inhibit 
transmitter release via A1 (or A2) receptors (Fig. 1). 
 
P2Y receptor families couple to Gq, Gs and Gi, hence modulating the activity of several types of 
voltage-gated ion channels via different G protein subunits. Upon stimulation with agonists, P2Y 
receptors inhibit N-type Ca2+ led to a reduced transmitter release or decreased neuronal 
excitability. P2Y12, 13 receptors inhibit N-type Ca
2+ channels and activate G protein-activated 
inward rectifier (GIRK or Kir3) K+ channels, both via Gβγ subunit. P2Y1, 2, 4, 6 receptors close N-
type Ca2+ channels via Gq and inhibit GIRK and M-type K
+ channels. However, P2Y1, 2 is able to 
open GIRK channels due to the crosstalk between Gq and Gi mediated pathways in which the 
receptors interact with Gαiβγ trimers. This interaction led to the release and binding of Gβγ 
subunits to the K+ channel. 
 
The release of ATP from astrocytes increased intracellular calcium via purinergic signaling 
(P2X2, 4, 5 ,7 and P2Y1, 2, 4, 14). The increased cytoplasmic calcium in turn stimulates the release of 
glutamate and other signaling molecules (aspartate, D-serine, nitric oxide and other neuroactive 
substances) from astrocytes to propagate the calcium wave to adjacent cells. The interaction 
between neuron and glia display an intercellular communication in the brain (Fields and 
Burnstock, 2006; Fischer and Krugel, 2007) 
 
  
1.5.1   Cell proliferation, migration and differentiation 
Purinergic signaling is present in the early stages of embryogenesis and is involved in 
processes of cell proliferation, migration and differentiation.  Nucleotides exert a synergic effect 
on cell proliferation in association with growth factors, chemokines or cytokines in early stages 
of development by parallel activation of MAPK kinase pathway and/or by transactivation of 
growth factor receptors.  
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Activation of NMDA receptors increases proliferation and differentiation of neural progenitor 
cells (Joo et al., 2007). The presence of purinergic antagonists of pyridoxalphosphate-6-
azophenyl-2’, 4’-disulfonic acid (PPADS), reactive blue 2 or suramin in P19 neural progenitor 
cells impaired activity of cholinergic and glutamate NMDA receptors in differentiated P19 cells. 
The reduced activity of sholinergic and glutamate NMDA receptors suggest  the participation of 
purinergic signaling in initiating downstream cascades of differentiation (Majumper et al., 2007, 




Table 1: Characteristics of human P2Y receptors. 
 





                                                                                                    Adapted from Fischer and Krugel, 2007. 
 
Figure 1: Schematic representation of purinergic signaling at central synapses. 
ATP may be produced by de-novo purine biosynthesis from 5’-phosphoribosyl-1-pyrophosphate (PRPP) 
and also by purine salvage pathways from adenosine (Ad) in neurons (and astroglial cells, not shown). 
ATP level in nerve terminals is generated via ADP mainly by oxidative phosphorylation in the 
mitochondria and may then be accumulated by carrier-uptake (vesicular ATP translocase) in synaptic 
vesicles (excitatory terminals likely present separate ATP- and glutamate-containing vesicles) as 
indicated. ATP released upon nerve stimulation from presynaptic terminals predominantly by exocytosis 
1) activates “fast” ionotropic P2X- and with other nucleotides “slow” metabotropic P2Y-R subtypes at the 
postsynaptic neuronal membrane 2) modulates its own release or that of co-transmitters via presynaptic 
P2X (maybe P2X1,2/3,3,7) and P2Y (P2Y1,2,4) auto-receptors and 3) triggers Ca
2+ signalling events in 
astrocytes via various P2X/Y-R (at least P2X2,4,5,7 and P2Y1,2,4,14). In addition, an astrocytic [Ca
2+]i rise can 
also be induced in response to neuronal glutamate release or by other neurotransmitters via activation of 
the corresponding receptors. The induced Ca2+ signals or propagated Ca2+ waves represent an important 
form of glial excitability and mediate glial-glial cell and glial-neuronal communication. The range of 
astrocyte-synapse interactions might be very complex. Subsequently, ATP and glutamate (Glu) are 
released from astrocytic processes enwrapping the synapse, which in turn modulate the activity of the 
nearby neurons and synapses or signal back to the astrocyte. Several enzyme families can degrade ATP 
(nucleotides). For example, the presynaptically localized ectonucleoside triphosphate 
diphosphohydrolase3 (NTPDase3) hydrolyzes ATP to ADP, which is a strong agonist on P2Y1,12,13-Rs, 
and ADP further to AMP. The cellular localization of other NTPDase enzyme isoforms needs to be 
defined. Ecto-5’-nucleotidase (5’-NT), which is also present at synapses and astrocytes, degrades AMP 
to adenosine. Adenosine can activate various P1-Rs. Not depicted, surface-located ecto-nucleotide 
kinases in astroglial cells can interconvert nucleoside di- and triphosphates. Other abbreviations: Ad-T, 
adenosine transporter; Gln-T, glutamine transporter; Glu-T, glutamate transporter; Gluc-T, glucose 
transporter; αq/11, αs, αi/o, βγ, different G protein signalling; (↑) indicates activation;(↓) indicates inhibition; 
(+) opening or (-) closure of ion channels (or positive/negative modulation of transmitter release). 
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1.5.2   Neuroprotection 
Impaired cells release nucleic acids and their metabolites such as nucleotides, nucleosides and 
uric acids to the environment. These nucleic acids and their metabolites are recognized by 
specific host receptors (Toll-like receptors, ROG-like receptors and NOD-like receptors) and 
purinergic receptors (P2X, P2Y and adenosine receptors) to trigger immune responses (Ishii 
and Akira, 2008). Macrophages detected increased nucleotides levels via P2Y2 receptor, 
responsive to both ATP and UTP, and initiate the release of Ca2+ from the endoplasmic 
reticulum. The calcium release, in turn, triggers surface channel to promote Ca2+ entry and 
refilling of stores (Rey et al., 2006). The influx of calcium is essential for T cell activation and 
proliferation (Carroll et al., 2006). Besides that, released ATP induced the activation of P2Y1 in 
the astrocytes. Subsequently, this led to the production of interleukin-6 (IL-6) to rescue the 
impaired cells (Fujita et al., 2008). 
 
1.6   Purine and aquatic animal 
Aquatic animals can detect, discriminate and respond to a variety of water-borne stimuli to 
reproduce, social interactions, feeding, and predator detection (Derby and Sorensen, 2008). 
Likewise, fish detect an array of chemicals in their environment for habitat recognition, food 
finding, conspecific identification and predator avoidance. In fish, pheromone associates to 
habitat recognition and reproduction whereas bile acids for alarm behaviour. Amino acids and 
nucleotides are always associated with feeding behaviour and mediated by both olfaction and 
gustation.   
 
In channel catfish, nucleotides are processed by dorsolateral of the olfactory bulb. Bile acids 
and amino acids are processed in the medial and lateral olfactory bulb respectively (Hansen et 
al., 2003). Likewise in zebrafish, bile salts and amino acids are processed in the medial and 
lateral OB respectively. Conversely, nucleotides are processed between the clusters responding 
to amino acids and bile salts (Li et al., 2005). The conservation of processing zone of odorants 
in olfactory bulb indicates that the odotopic map is preserved in the fish. This odotopic map is 
further preserved in the forebrain of channel catfish. Feeding cues of amino acids and 
nucleotides are represented in lateral, palllial portions of the forebrain in the channel catfish. 
Nucleotides responsive units were situated in the lateral half of the telencephalon near the 




ATP is abundantly found in living organism due to their importance in carrying out biological 
processes. Therefore, ATP presents in high concentration in animal flesh but decays rapidly as 
cells die (Sikorski et al., 1990). Thus, ATP is an indicator for food. In spiny lobster, ATP 
stimulates carnivorous feeding while AMP inhibits feeding (Zimmer-Faust et al., 1988). In 
seawater, the level of ATP is minimized in the background by dephosphorylating enzymes and 
nucleotidases. Consequently, the presence of significant concentrations of ATP in seawater 
provides a reliable indicator that food source is nearby (Burnstock, 1996). The detection of 




1.7   Purinergic receptor and olfaction 
Hegg and colleagues (2003) reported that purinergic receptors modulate odor sensitivity in 
mice. Damaged cells release ATP, thereby activating purinergic receptors on neighboring 
sustentacular cells, olfactory sensory neurons, and basal cells and initiating a cascade for 
neuroprotection and regeneration. Calcium can modulate a number of receptors, enzymes, and 
channels involved in odorant signal transduction. The increase in intracellular calcium by 
purinergic transduction triggers homeostasis mechanisms that potentially alter odor sensitivity.  
 
Although P2Y1 and P2Y2 are detected in olfactory epithelium and vomeronasal organ of the rat, 
both of the receptors seems not involve in chemosensation signaling. P2Y1 is involved in the 
proliferation of epithelial cells in olfactory epithelium. Although P2Y2 is detected within the 
neurosensory epithelium of vomeronasal organ, it was postulated that it is involved in mediating 
mucin secretion (Gayle and Burnstock, 2005). 
 
In olfactory epithelium of Xenopus tropicalis tadpole, ATP activates a large number of 
sustentacular cells and to a lower extent, olfactory sensory neurons. Upon activation by ATP, 
sustentacular cells may secrete components that influence the composition of the mucus in 
olfactory epithelium and thereby, could affect the olfactory perception (Czesnik et al., 2006). 
 
P2Y receptor could be olfactory receptor or could be the charaperone of OR. The association of 
purinergic receptors (P2Y1, P2Y2 and A2a) with olfactory receptor M71 in HEK-293 cells 
enhances plasma localization of M71. The enhanced plasma localization with purinergic 
receptors was also observed in M71 subfamily members, but not distantly related members. 
This association suggesting that the interaction purinergic receptor is confined to a restricted 
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population of OR. The OR interactions with other receptors may act in concert with OR 
associations with accessory proteins to control OR trafficking (Bush et al., 2007). 
 
1.8   Zebrafish as model organism 
The zebrafish is an important model system for genetic and developmental studies (Kimmel, 
1993). It has the combination of the best virtues of all other models which includes easily 
accessible embryos, simple breeding and short generation time. Besides that, the embryos are 
completely transparent during early development facilitating visualization. The organs in 
zebrafish larvae composed of fewer cells compared to other vertebrate model even though the 
organ functions in much the same way as in other vertebrates. All these attributes make 
zebrafish a desirable model to work with. 
  
1.9   Aims: 
 
The aim of this thesis is to lay the foundation for a comprehensive analysis of the P2Y receptor 
family in aquatic model system, zebrafish. Previously, most of the P2Y receptor studies are 
conducted in pharmacology research. Only a few studies have been conducted in vertebrate 
development. In particular, nearly nothing is known about the possible role of P2Y receptors in 
zebrafish, Hence, the aims of this project are: 
i) To identify P2Y receptors and delineate the family in teleost 
ii) To understand the evolutionary dynamics of P2Y receptor 












2.   RESULTS 
 
2.1   P2Y-like genes in teleost 
A recursive database search against 5 teleost species (Danio rerio, Gasterosteus acualeatus, 
Oryzias latipes, Tetraodon nigroviridis and Takifugu rubripes) with eight functional human P2Y 
receptors as a query has led to the identification of 42 orthologues. Further bioinformatic 
analysis revealed an additional 185 GPCRs that showed a high degree of structural similarity 
with P2Y receptors. (Zebrafish (Danio rerio) have the largest family, with 68 genes. This is 
followed by stickleback (Gasterosteus acualeatus) and medaka (Oryzias latipes) whose P2Y 
families are comprised of 48 and 40 genes respectively. Lastly, 35 genes and 36 genes 
constitute the tetraodon (Tetraodon nigroviridis) and fugu (Takifugu rubripes) P2Y families, 
respectively. 
 
To analyse the genesis of the P2Y family, database searches were performed in jawless and 
cartilaginous fishes. Twenty four P2Y genes were identified in the lamprey (Petromyzon 
marinus) genome, and 24 genes in the elephant shark (Callorhinchus milii) genome. The 
number of genes in these two species might not be the complete number as the genome 
projects are still in progress, and the genome coverage for shark is only 1.4 fold. A single p2y-
like gene was found in little skate (Raja erinacea), another cartilaginous fish with only partial 
genomic sequence information available (Table 2).  
 
To pinpoint the evolutionary origin of the P2Y family, database searches were extended to the 
ancestral chordate species, Ciona intestinalis, an ascidian. Only one candidate with rather low 
homology was found, but it turned out not to fulfil the inclusion criteria (see Methods), as it did 
not exhibit the seven transmembrane domain structure.  
 
Intriguingly, the number of P2Y-like genes is not much different between Xenopus tropicalis and 
human (39 and 33 genes respectively). This suggests that those genes retained in the 
vertebrate transition from water to land may have kept their function. In contrast, large 
differences in family size are observed between teleost species, suggesting a dynamic 
adaptation to changing environmental conditions. 
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Table 2: P2Y genes in 10 vertebrate species. 
      Dr Ga Ol Tn Tr Re Cm Pm Xt Hs 
Total 68 48 40 35 36 1 24 24 39 33 
Funtional genes 67 45 38 31 33 1 19 20 36 33 
Pseudogenes or partial sequences 1 3 2 4 3 - 5 4 3 - 
 
Abbreviations: Dr, zebrafish; Ga, stickleback; Ol, medaka; Tn, tetraodon; Tr, fugu; Re, little skate; Cm, 
elephant shark; Pm, lamprey; Xt, frog; Hs, human. 
 
 
2.2   P2Y genes are paraphyletic 
To investigate the phylogenetic relationship of the P2Y receptors and candidate proteins 
obtained above, methods of neighbour joining (NJ), maximum parsimony (MP) and maximum 
likelihood (ML) are used. The three methods gave slightly varying tree topologies with the ML 
tree having the best resolution (Fig. 2). Olfactory receptors were used as an outgroup. Both 
olfactory receptor and P2Y receptor belong to the delta subgroup of GPCR class A receptor 
family. Hence, the olfactory receptor family is the nearest phylogenetic relative of the P2Y 
receptor family. Phylogenomic analysis revealed that P2Y receptor family is paraphyletic. Within 
the P2Y clade two other gene groups are contained, platelet-activating factor receptors and 
succinate receptors. These ‘internal outgroups’ are interspersed between two phylogenetically 
distinct subgroups of P2Y receptors. This is consistent with an earlier report by Abbracchio et al 
(2006). Within the P2Y clade a large number of orphan GPCRs are clustered together with the 
functional P2Y receptors, suggesting the presence of yet to be characterized P2Ys. Moreover, 
leukotriene cysteine, EBI2 and free-fatty acids receptors are close neighbors in the phylogenetic 
tree indicating that P2Y and related receptors exhibit high diversity both in sequences and 
ligands.  
 
According to the International Union of Pharmacology, the term ‘P2Y’ is used for functional 
receptor proteins and the lowercase ‘p2y’ is used for mammalian orphan receptors or functional 
nonmammalian receptors without a mammalian orthologue. Hence, I have named the fish 
sequences according to their human orthologue. In the case that non-nucleotide ligands are 
known for a mammalian receptor, the orthologous fish sequence is named after the mammalian 
gene. The receptors within the P2Y family with unknown ligand are named as p2y-like (p2y-l) as 





Figure 2 | Phylogeny of teleost with other vertebrate P2Y families.  
A maximum likelihood tree was constructed based on the alignment of predicted amino acid 
sequences with 100 bootstrap replicas. 227 teleost P2Y (red), 24 shark P2Y (light blue), 1 little 
skate (dark blue), 24 lamprey P2Y (yellow), 28 frog P2Y (green) with human P2Y (purple). 
Olfactory receptors (black) were used to root the tree. Both platelet-activating factor and 
succinate receptors served as internal outgroups of the P2Y family and are labeled in brown.   
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2.3   P2Y gene gains and losses in the teleost and tetrapod lineage   
All P2Y genes identified clustered into 19 major clades divided into 38 subfamilies. Nearly all of 
the subfamilies contain tetrapod and teleost genes in each clade demonstrating that members 
of the subfamily have established before the divergence of Actinopterygii and Sarcopterygii. 
However, two of the subfamilies did not have a mammalian orthologue (p2yl-3 and p2yl-4) even 
though the orthologue is present in Gallus and Xenopus (Appx 7.2A). The absence of the 
mammalian orthologue implied that the vertebrate orthologue is lost in the mammalian lineage. 
On the other hand, several gene expansion events occurred in the teleost fish lineage, in eight 
of the subfamilies (P2Y2, P2Y4, p2y5, p2y7, p2y15, p2yl-7, p2yl-13 and p2yl-14). These gene 
duplications have occurred at different stages in evolution, as visualized by their presence in 
different subsets of teleost species. This scenario is displayed by P2Y4 and p2y15 clades in 
which the expansion only occurred in zebrafish, whereas P2Y4 and p2y15 remained a single 
gene in other teleosts. Furthermore, species-specific expansion in p2yl-13 clade only involved 
zebrafish (Fig. 3) and stickleback.  
 
More than 60% of the clades have the full set of orthologues for each of the five analysed 
teleost fish genomes. It cannot be excluded that the lack of some orthologues in the remaining 
clades might be due to the inadequacy of the currently available databases. However, there is 












Figure 3 | Phylogeny of zebrafish P2Y gene and ligand correlation. 
Phylogenetic tree of P2Y genes identified from zebrafish (68 genes), shark (24 genes) and 
human (33 genes). The tree was constructed using ML method with 100 bootstrap replicas. The 
branches are coloured to facilitate the identification of subfamilies. Dark green and black 
braches indicate internal and external outgroups respectively. The gene name is colour-coded 
according to the ligand: red, nucleotides; blue, lipid derivatives; orange, nucleotides and lipid 
derivatives; purple, α-ketoglutarate; green, unknown ligand. Underline gene names are 
candidates used for subsequent analysis. 
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2.3   Correlation between phylogenetic location and ligand 
To examine the relationship between phylogenetic location and known ligand specificity, I have 
graphed the ligand specificity onto the maximum likelihood tree in Figure 3. Ligand information 
was collected for human P2Y receptors. Most receptors in this family bind either to nucleotide or 
lipid derivatives. Phylogenetic clusters of receptors that bind to similar types of ligands are 
present. However, this correlation is only partial, and there are several examples of 
phylogenetically neighboring receptors with rather different ligands, and also examples of 
phylogenetically distant receptors sharing a ligand. 
 
 Some examples of ligand promiscuity of the receptor are the activation of P2Y12 by both ADP 
and leukotrienes (Nonaka et al., 2005) and the activation of cysteine leukotriene receptor 1, 
cysteine leukotriene receptor 2 and Gpr17 by leukotrienes as well as UDP at nanomolar 
concentration (von Kuegelren, 2005).  The large difference in chemical structure of these two 
endogenous ligands indicates the complexity of the ligand-receptor interactions in the diverse 
P2Y family. 
 
The primitive P2Y-receptor found in the little skate Raja erinacea does not discriminate between 
different nucleotides agonists such as ATP, ADP or UDP (Dranoff et al., 2000). In contrast, 
mammalian P2Y1 which forms a sister clade with Raja erinacea P2Y-receptor is potently 
activated only by adenine nucleotides and not by uracil nucleotides (Fischer and Kruegel, 2007). 
Thus, ligand selectivity of orthologues exhibits major species differences indicating a fine-tuning 
process during evolution. Hence, ligand-binding analysis of the P2Y repertoire with a whole 
range of species will be instructive. 
 
2.4   P2Y genes have an early origin in jawless fish 
The presence of P2Y orthologues in jawless and cartilaginous fishes revealed an ancient origin 
of this family of receptors. Sea lamprey P2Y genes usually form very basal branches (Fig. 2) 
inferring that the ancestral genes for these families existed before the segregation in jawless 
and jawed fish, about 560 million years (Volff, 2005). The phylogenetic analysis displayed that 
sea lamprey receptors did not always have one-to-one orthologue with human and teleost 
species. In some cases, sea lamprey representation is missing in the clade. There are two 
possibility of the absent in the clade, either the ancient sea lamprey gene have been lost during 




The clustering of sea lamprey genes, basal to the three subfamilies (p2yl-1, p2yl-2, cysteine 
leukotriene receptor) indicating an independent duplication event occurred in lamprey lineage. 
These genes formed a paralogue group within lamprey lineage.  In few cases, sea lamprey 
gene is the ancestral of duplicate genes of higher species. Sea lamprey gene, P2Yu is ancestral 
gene of p2y5 and p2y9. The duplication of this orthologue occurred after the divergence from 
the jawless vertebrate.  
 
On the other hand, elephant shark P2Y genes are distributed uniformly in the tree. Almost all 
the clades have orthologues shark gene and phylogenetically, the gene is located deep within 
the teleost clade demonstrating that the P2Y families are already established in the common 
ancestor of shark and bony fish.  
 
Surprisingly, lamprey and elephant shark orthologues are not present in free-fatty acid receptor 
clade. The absence of the representatives from basal vertebrate raises the question whether 
free–fatty acid receptors arise only after the divergence of bony vertebrates.  This will remain to 
be elucidated until both the lamprey and elephant shark genomes have been fully sequenced.  
 
The distribution of the P2Y gene in the phylogenetic tree closely reflects the phylogenetic 
relationships of the species. The two pufferfish studied belong to the same family 
(Tetraodontidae) and their orthologues are closer related to each other than to those from any 
other species. The stickleback and medaka orthologues constituted their next neighbors, as 
pufferfish, stickleback and medaka belong to three subdivisions of the same superorder 
Acanthopterygii (orders Tetraodontiformes, Gasterosteiformes, and Beloniformes respectively). 
In all cases the zebrafish orthologues occupy the most distant position (zebrafish being the 
evolutionarily most distant fish in this comparison, as it is an Ostariophysi, unlike the four other 
species which belong to a Neoteleostei.  
 
2.5   Global negative selection in teleost P2Y genes with a few positives sites 
To investigate the evolutionary dynamics of P2Y genes, selective pressure analysis is 
conducted in teleost P2Y genes using both global and local analysis of substitution rates in non-
synonymous (dN) vs. synonymous (dS) sites in 31 of the subfamilies. The remaining seven 
subfamilies are not included in the analysis due to the lack of number of genes. The global 
dN/dS values calculated for each of the groups ranging from 0.08 to 0.42, with an average of 
0.23, indicating that P2Y genes are subjected to purifying selection (Fig. 4a).  The purifying 
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selection is against amino acid changes in protein-coding genes, hence suggesting that these 
genes are slow evolving genes.  
 
Global analysis of negative selection could mask positive selection on a few amino acid sites. 
Site-by-site dN/dS analysis of the P2Y genes revealed a positively selected site in two of the 
analysed groups, p2yl-4 (Fig. 4d) and p2yl-7 (Fig. 4e). These sites are located in TM5 and N-
terminal in p2yl-4 and p2yl-7 respectively. Conserved residues in TMs 3, 6 and 7 are likely to 
contribute to the binding pocket of the P2Y receptor (Erb et al., 1995; Jiang et al., 1997; Moro et 
al., 1998; Hoffman et al., 1999; Moro et al., 1999; Qi et al., 2001; Guo et al., 2002; Harold et al., 
2004). All the positively selected sites are not positioned at the binding pocket indicating that the 
ligand specificity is most likely conserved in teleost lineage. 
  
2.6   High conservation in transmembrane domains 
To analyse the sequence similarity of the P2Y genes, pairwise comparisons are performed. P2Y 
genes showed low identity values (20-50%) indicating that this class of receptors is highly 
divergent in the amino acid composition (Appx. 7.2C). Across the species, homologues of a 
subtype have a higher homology and sequence conservation. For example, in the P2Y1 clade, 
zebrafish shared more than 60% of identity with little skate, elephant shark and human. The 
shared identity is extended to more than 80% in teleost species (data not shown). 
 
P2Y receptor belongs to the rhodopsin family of GPCR. Therefore, distinct amino conservation 
is much more prevalent in transmembrane region than non-transmembrane region. Nine 
sequence motifs of rhodopsin family is conserved in P2Y receptors (‘N’ in TM1, ‘L’ in TM2, ‘C’ in 
EC1 and EC2, ‘R’ in IC2, ‘W’ in TM4 and, ‘N’, ‘P’ and ‘Y’ in TM7). Besides that, P2Y also shared 
a conserved amino acid with VIR and ORA respectively (‘G’ in TM1 and ‘S’ in TM3). In addition, 
a conserved proline (P) in TM5 is also present in ORA, T2R and TAAR suggesting that this is a 
general motif of rhodopsin family (Fig. 5). 
 
Next, consensus motifs are analyzed to search for characteristic sequence motif of this receptor 
family in fish. There are three consensus motifs reported for functional P2Y receptors in 
mammals. First, all known P2Y receptor subtypes possess 4 cysteine residues at their 
extracellular domain (Hoffmann et al., 1999; Ding et al., 2003). Second, a conserved consensus 
sequence of “S(I/V)(L/I)FLTCIS” in TM3 (Kuegelgen and Wetter, 2000). And third, an “Hxx(R/K)” 
motif is present in TM6 (Abbracchio et al., 2006). The internal outgroups, platelet-activating 
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factor and succinate receptors possessed two of the three motifs listed above, emphasizing the 
high structural similarity with P2Y receptors. Both platelet-activating factor and succinate 
receptors possessed “S(I/V)LFLxxIS, HxxQ”  and “SILF(L/M)xxxS, HxxR” motifs at TM3 and 
TM6 (data not shown). The conservation of cycteine residue is also extended to the outgroups. 
Platelet-activating and succinate receptors retained cysteine residue at two and three of the 
extracellular domain respectively. However, conserved cysteine in N-terminal is absent in both 
receptors. Therefore, the cysteine residue in N-terminal may serve as a signature motif in 
identifying members of P2Y family.      
 
The analysed subfamilies that possesed 4 cysteine residues in the extracellular loop are 
grouped into 3 classes: i) P2Y receptor; ii) uncategorized receptors that have known ligand 
(gpr55, gpr65, gpr68, gpr132 and cysteine leukotriene receptors) and iii) orphan receptors that 
have no known ligand (p2yl-2, p2yl-3, p2yl-4, p2yl-6, p2yl-7, p2yl-8, p2yl-11, p2yl-12, p2yl-13 
and p2yl-14). This motif shared by P2Y receptor and orphan receptors may help to identified the 
yet remaining P2Y members.   
 
Although the receptors possessed conserved sequence motifs, most of the motifs are also 
present in platelet-activating and succinate receptors. Both the receptors intertwined P2Y 
receptors in the phylogenetic tree. Hence, it is not surprising for platelet-activating and succinate 
receptors to share a high sequence similarity to P2Y receptor. Despite the high conservation of 
P2Y receptor with other receptors of rhodopsin family, yet three P2Y-specific motifs are located; 










Figure 4 | Evolutionary distances and selective pressure on P2Y genes. 
(A) dN/dS ratios of 31 teleost P2Y subfamilies. dN/dS analysis is conducted only in group that 
contain more than 2 genes. dN/d >1 indicates positive selection;  dN/dS < 1, purifying selection; 
and dN/dS =1, neural selection. The group average ratio is indicated by background shading. 
(B-E) A representative site-by-site selective pressure is shown for four P2Y sequences 
(negative selection in light blue, p<0.2 or blue, p<0.1, neutral selection in grey, positive selection 
in orange, p<0.2 and red, p<0.1.  
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Figure 5 | Positively selected amino acid site in teleost p2yl-7. 
Red shaded indicates positively selected amino acid site in N-terminal. Yellow shaded indicates 






Figure 6 | Conserved sequence motifs of P2Y family. 
Conservation of predicted amino acid sequence for the fish P2Y repertoire is displayed as 
sequence logo. The regions corresponding to the transmembrane (TM) domains and the 
extracellular and intracellular (EC and IC) domains are numbered and indicated. Crosses 
represent residues generally conserved among other class A GPCR families and circles 
represent residues conserved in platlet-activating and succinate receptors. Triangles represent 
residues conserved between P2Y and V1R. Squares represent aresidues conserved between 
P2Y and ORA. Filled squares represent residues conserved between P2Y, ORA, T2R and 
TAARs. Asterisks represent conserved residues found only in P2Y.    
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2.7   Genomic distribution of zebrafish P2Y genes 
In zebrafish genomes, P2Y genes are distributed broadly, residing on 20 chromosomes. The 
genes are distributed both as singleton and cluster (Fig. 7). There is one major cluster 
containing 10 genes on chromosome 15. Several small clusters comprise of two to four genes 
are also found on chromosome 1, 2, 5, 7, 9, 14, 17, 18 and 19. The rest of the genes existed as 
singletons residing in other chromosomes except on chromosome 8, 11, 12, 22 and 25.  Only 5 
of the identified P2Y genes remain unassigned to any chromosomes.  
 
The genomic location of ten listed genes in the major cluster in chromosome 15 concurred with 
the phylogenetic analysis inferring the presence of expansion event. Furthermore, the genes in 
the cluster are arranged in the tandem as in phylogenetic analysis postulating the existence of 
correlation between genomic linkage and phylogenetic relationship. 
 
The ten genes are arranged in the order of: P2Y12, P2Y13, p2yl-13b, p2yl-13a, P2Y14, p2yl-13e, 
p2yl-13f, p2yl-13d, p2yl-13c and p2yl-12 (Fig. 8a). The cluster composed of P2Y12, P2Y13, P2Y14 
and p2yl-12 is evolutionary well-preserved. This is supported by shared genomic location in 
elephant shark (cluster 405), stickleback (chromosome I), medaka (chromosome 13), tetraodon 
(chromosome 16) and human (3q24-3q25) (Schoeneberg et al., 2007; Venkatesh et al., 2007). 
The addition of p2yl-13 subfamily into gene cluster of zebrafish demonstrated the gene 
expansion via gene duplication. 
 
Two intrachromosomal duplication events have taken place. The first duplication event 
generated p2yl-13a and p2yl-13b from p2yl-12. Then, it was followed by second duplication 
event, producing p2yl-13c, p2yl-13d, p2yl-13e and p2yl-13f on chromosome 15 in zebrafish. The 
four genes may be originated from p2yl-13a and p2yl-13b based on the phylogenetic 
relationship. Besides zebrafish, the second duplication occurred only in stickleback although the 
duplicated gene is translocated to a different chromosome.  
 
Second duplication event is not presence in other fish species suggesting either the duplication 
event is limited to zebrafish and stickleback only or the cluster of genes is lost in other species 









Figure 7 | Chormosomal distribution of zebrafish P2Y genes. 
The P2Y genes are distributed in both as singletons and small clusters in the zebrafish genome. 
The genes are distributed in 20 chromosomes and only 5 genes remained unassigned in any of 




2.8   Syntenic relationships of teleost P2Y 
The comparison of genomic location of P2Y genes in zebrafish, stickleback, medaka and 
tetraodon revealed a remarkable degree of synteny across the fish species. Two homologous 
segments are identified. The identified segments possessed synteny distances similar to 
phylogenetic relationship.  
 
The first paralogon has a large number of genes consist of both P2Y receptors (P2Y1, P2Y2, 
p2y5, P2Y6, P2Y12, P2Y13 and P2Y14) and orphan receptors (p2yl-11 p2yl-12, p2yl-13, Gpr4, 
Gpr92, Gpr132). The segment displayed disrupted synteny as the genes are scattered across 3 
chromosomes in zebrafish and tetraodon, 2 chromosomes in medaka and 1 chromosome in 
stickleback (Fig. 8a). The second paralogon displayed conserved synteny. The genes (P2Y4, 
p2y9, p2y10, p2yl-8 and cycteine leukotriene receptor 1) included in the second homologous 
segment are distributed in a single chromosome in all analysed species (Fig. 8b). Stickleback 
and tetraodon shared a high conserved linkage. Both species shared the conservation of both in 
synteny and order of homologous genes.  
 
In both segments, members of syntenic groups of medaka are more susceptible to inverted 
order. The inverted order of syntenic groups implying a higher frequency of intrachromosomal 



















Figure 8 | Conserved synteny in fish species and human. 
Conservation of synteny of genes in zebrafish chromosomes compared to Gasterosteus 
aculeatus (GA), Tetraodon nigroviridis  (TN) and Oryzias latipes (OL). Genes are ordered 
according to their genomic positions. Grey bar indicates non-conserved gene. Synteny of genes 
residing in chromosome 9, 15 and 16 (A) and, chromosome 14 (B) in zebrafish compared to 3 
other fish species. Grey bar represents other genes. 
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2.9   Genomic structure of P2Y genes 
Currently, human P2Y receptors are the well-studied in comparison to other available species. 
Most of the human functional P2Y receptors do not contain introns. Only one of the receptor, 
P2Y11, has an intron after the third amino acid. In contrast, the analysed genes of seven fish 
species and a frog species possessed a mixture of gene structure, varied from intronless to 
multiexonic structure (Fig. 9). Most of the analysed genes (75%) are intronless. The remaining 
25% of the analysed genes possessed intron, with the number of introns varied from one to five 
(Table 3). At present, all the analysed genes in lamprey and elephant shark are intronless. 
However, the intronless structure is not well-preserved in bony fish. This is displayed by the 
presence of multiexonic structure suggesting possibly an intron-gain event occur in the bony fish 
evolution. 
In zebrafish, 81% of the genes are intronless, 13% acquired an intron, 4% acquired 2 introns 
and only 2% acquired 3 introns in their gene structure. On the contrary, the percentage of 
intronless gene in neoteleost species is much reduced ranging from 56% to 63%. The 
proportion of genes that possessed multiexonic structure is increased. Additionally, the number 
of insertion of introns extended to 5 introns in stickleback, tetaodon and fugu (ranging between 
2 to 3%).    
 
The multiexonic genes are scattered across the phylogenetic tree suggesting that the intron-
gained event is a random process. Frequently, if a member of the clade acquired an intron, 
most of the remaining members would acquire introns as well (e.g P2Y13). Generally, neoteleost 
species would acquire an additional insertion of intron in comparison to zebrafish, an 
ostariophysan. Occasionally, only one member of the clade acquired intron whereas other 
members of the clade remained intronless as in the case p2y5b in medaka, in which an intron-
gain event took place. A very rare and interesting case is in p2y10 clade. Every member of the 
clade acquired a different number of intron. Zebrafish acquired an intron in the gene structure 
whereas stickleback, medaka and fugu acquired two, three and four introns respectively. 
Tetraodon p2y10 sequence is incomplete and currently, remained intronless. This variance 
displayed the dynamicity of intron-gain event in different genes and lineages. The intronless 
structure of P2Y gene in lamprey is well-preserved in the mammalians, given that almost all 
tetrapod P2Y genes appear to be monoexonic. In contrast, teleost fishes appear to be 
susceptible of insertion of intron. The differences in gene structure preservation between 
mammals and teleost which share a common ancestor suggests that a higher propensity of 
intron insertion in Actinopterygii lineage but less in Sarcopterygii (Fig. 10).   
39 
 
Table 3: Gene structure distribution in 8 vertebrate species 
 
Organism Intronless 1-intron 2-intron 3-intron 4-intron 5-intron  Total 
Danio rerio 55 (81) 9 (13) 3 (4) 1 (2) - - 68 
Gasterosteus aculeatus 27 (56) 9 (19) 8 (17) 3 (6) - 1 (2) 48 
Oryzias latipes 24 (60) 9 (22) 4 (10) 3 (8) - - 40 
Tetraodon nigroviridis 22 (63) 7 (20) 4 (11) 1 (3) - 1 (3) 35 
Takifugu rubripes 22 (61) 7 (19) 3 (8) 2 (6) 1 (3) 1 (3) 36 
Callorhinchus milii 24 (100) - - - - - 24 
Petromyzon marinus 24 (100) - - - - - 24 
Xenopus tropicalis 38 (97) 1 (3) - - - - 39 
Total 236 (75) 42 (13) 22 (7) 10 (3) 1 (1) 3 (1) 314 
 
The genes in each species (row) are grouped according to their structure, varied from intronless to 
multiexonic (column). The number indication of total of genes in each species that possessed the 





Figure 9 | Gene structure distribution in 7 fish species and human. 
The P2Y genes have a mixture of intronless and multiexonic structure in fish species and 
human. The distribution of the gene structure is depicted in stacked bar graph.  X-axis denotes 
the number of genes and Y-axis denotes analysed fish species. Light green represents 






Figure 10| Estimated minimal evolutionary age and intron dynamics of P2Y subfamilies. 
(A) Open squares represent gene gain events in each lineage and black squares represent 
gene loss events. The name of the subfamilies is indicated inside each square. (B) Open 
squares represent intron gain events whereas black squares represent intron loss events. The 
major phylogenetic transitions are indicated: Bo/NoBo, bony fish/cartilaginous fish; Ac/Sa, 
actinopterygian/sarcopterygian split; Os/Neo, ostariophysii/neoteleostei segregation. The 
number indicates P2Y subtypes; l , p2y-like; G, G-protein-coupled receptor; CysLtr, cysteine 
leukotriene receptor.  
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2.10   P2Y genes are broadly expressed in adult tissue 
Nine P2Y candidates are randomly selected to be characterised. These genes are P2Y1, P2Y4, 
p2y5, p2y10, FFAR2c, Gpr35b, Gpr35c, p2yl-6 and p2yl-10a. To analyse the expression pattern 
of the selected candidates, RT-PCR is performed on twelve adult tissues (barbel and lips, 
olfactory epithelium, eye, brain, gills, heart, liver, stomach, kidney, testis, spleen and skin). All 
the analysed candidates’ transcript is detected in gills. All but one, FFAR2c, of the candidates is 
expressed in olfactory epithelium, brain, spleen and testis.  Only Gpr35a and p2yl-10a exhibited 
transcripts in the skin tissue (Fig. 11). FFAR2c only have transcript in gills but not in other 
analysed tissues. The specific expression of FFAR2c suggests that FFAR2c may play a role in 
gills.  The remaining of the candidates displayed a broader expression, normally in several 
tissues, suggesting they may involve in general role in maintenance and development. Although 
Gpr35a and Gpr35c are clustered together in the phylogenetic analysis, the two genes 
displayed a different expression pattern. Gpr35a transcript is found in all the analysed tissue. In 
contrast, Gpr35c transcript is expressed only in olfactory epithelium, brain, gills, stomach, 
kidney, testis and spleen. The differences in the expression pattern suggest that the genes 
might undergo partitioning of functions. 
 
   
Figure 11 | Broad expression of P2Y transcripts in different types of adult tissues. 
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RT-PCR indicating transcription of P2Y genes are found in several adult tissues. PCR 
amplifications were performed by using gene specific primers that amplify between 300 to 
400bps. Beta-actin was used as a quality control for the cDNA generated. Genomic-
contaminated cDNA would generate 800bps band whereas genomic-free cDNA generates 
500bps band. Genomic DNA (Ge) in the last lane is a positive control for the PCR. Adult tissues 
used are as follows: BL, barbels and lips; OE, olfactory epithelium; E, eye; B, brain; G, gills; H, 
heart; L, liver; St, stomach; K, kidney; T, testis; Sp, spleen; Sk, skin. 
 
 
2.11   Expression of P2Y in larvae 
Whole mount in situ hybridisation is carried out on 5 days post fertilization (dpf) zebrafish larvae. 
At 5dpf, the larvae have completed organogenesis and major behavioural patterns are 
developed. All the analysed genes were expressed in the brain and pharyngeal arches which 
aftermath, give rise to gills. This expression data corresponds to PCR results. Expression 
pattern of P2Y4 and p2yl-10a are not included as the sense probe showed similar labeling as 
the antisense probe albeit at lesser intensity. Sectioning is performed on larvae to analyse the 
expression pattern in details in particularly in regions which are not accessible by light 
microscope of whole-mount larval.  
 
P2Y1 
P2Y1 transcripts are detected in the central nervous system, otic vesicle and pharyngeal arches. 
Sectioning of the 5dpf larval revealed the expression in the brain and spinal cord that formed the 
component of central nervous system. In the brain, the expression is restricted to the ventricular 
regions in telencephalon, diencephalon and rhombencephalon, and midbrain hindbrain 
boundary (Fig. 12A-B, D-F, H-M). Similarly, P2Y1 transcripts are also detected in the ventricular 
zone of spinal cord (Fig. 12G, K-M) that is extended from rhombencephalon, but not in floor 
plate. Besides that, P2Y1 transcripts are also detected in pharyngeal arches. The expression is 
observed only at the tips of the branchial arches (Fig. 12N). A weaker expression is observed in 
Merkel’s cartilage (Fig. 12C-D). In addition, P2Y1 transcripts are also detected in pectoral fin 












Analysis of P2Y1  expression in  5dpf larval by whole mount in situ hybridization. Panel (A-C), 
whole mount, (D, K-O) coronal and (E-J) transverse sections after hybridization. A) Lateral view 
shows expression in brain including midbrain hindbrain boundary, otic vesicle and branchial 
arches; (B) Dorsal view shows expression in the cerebellum; (C) Ventral view shows expression 
in pharyngeal branches and pectoral fin; Expression is detected in the telencephalon (E, K-M), 
diencephalon (E, K-L) and rhombencephalon ( F-M) in the brain; The expression is restricted to 
the ventricular region of the spinal cord  (G, L-M); The edges of branchial (*) and hyoid arches 
are labeled as well as pectoral fin (N); (O) Sense riboprobe. Abbreviations: BA: branchial 
arches; CCe; cerebellum; CMZ, ciliary marginal zone; DC: diencephalon; E: eye; eth: ethmoid 
plate; FP, floor plate; Ha, habenula; Hy: ceratohyal; Ki, kidney; ; MA: mandibular arches; MC, 
Merkel’s cartilage; MHB: midbrain hindbrain boundary; MO: medulla oblongata; OG, octaval 
ganglion; OV: otic vesicle; P: pallium; pq: palatoquadrate; PF: pectoral fin; SB, swimming 





p2y5 is broadly expressed in brain. It shared a similar expression of P2Y1 in ventricular regions 
in telencephalon, diencephalon, rhombencephalon and spinal cord (Fig. 13B, D, L). In additions, 
p2y5 transcripts are also strongly detected in habenula (Fig. 13I) and midbrain hindbrain 
boundary (Fig. 13A, B, E, J). A weaker expression is also detected in pallium (Fig. 13F and H) 
and craniofacial mesenchyme (Fig. 13H) adjacent to developing cartilage tissue. Expression in 
peripheral nervous system is detected in trigeminal ganglion (Fig. 13J) and octaval ganglion 
(Fig. 13K). The former is involved in mechanosensory system and the latter in auditory system. 
In pharyngeal arches, p2y5 expression is detected in branchial arches (Fig. 13G), 
palatoquadrate (Fig. 13H) and Merkel’s cartilage (Fig. 13C).  
 
p2y10 
The expression of p2y10 is limited to dorsal pallium (Fig. 14E), midbrain hindbrain boundary (Fig. 
14A), medulla oblongata (Fig. 14F) and vagal ganglion (Fig. 14A and F) in the brain. Pharyngeal 
region and kidney (Fig. 14G) is strongly label by the transcripts.  Additionally, p2y10 transcripts 
are also detected in craniofacial mesenchyme adjacent to ethmoid plate and in ciliary marginal 
zone of the eye (Fig. 14E).   
 
p2yl-6 
In the brain, p2yl-6 transcripts are detected in telencephalon (Fig. 15F), thalamus (Fig. 15L), 
proliferating ventricular regions in mesencephalon and rhombencephalon (Fig. 15F), midbrain 
hindbrain boundary (Fig. 15B, F) and medulla oblongata (Fig. 15M-O).  Strong expression of 
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p2yl-6 transcripts are also observed in pallium (Fig. 15F) and vagal ganglion (Fig. 15A, N, O). 
Besides brain region, p2yl-6 is also expressed strongly in pharyngeal regions of palatoquadrate 
and ethmoid plate, craniofacial mesenchyme region (Fig. 15K), and tips of pectoral fin (Fig. 15E 
and O). A weaker expression is detected in tips of branchial arches, Merkel’s cartilage (Fig. 
15D) and otic vesicle (Fig. 15J). 
 
Gpr35a 
Gpr35a is expressed in the brain and pharyngeal regions. In the brain, the expression is 
distributed from anterior region of the subpallium to medulla oblongata in rhombencephalon 
(Fig. 16D-G, I). The expression in pharyngeal regions is broadly distributed in branchial (Fig. 
16C and J) and mandibular arches with strongest expression observed in palatoquadrate (Fig. 
16D). In addition, Gpr35a transcripts are labeled in kidney (Fig. 16H), vagal ganglion (Fig. 16G) 
and ciliary marginal zone in the eye (Fig. 16D). 
  
Gpr35c 
Gpr35c shared a similar expression as Gpr35b in 5dpf larval. In the brain, the expression of 
Gpr35c is detected from anterior region of the pallium (Fig. 17H) through medulla oblongata in 
rhombencephalon (Fig. 17F). Likewise in pharyngeal region, the transcripts are detected in 
brachial arches with the strongest expression observed in mandibular and hyoid arches (Fig. 
17C, E). A cluster of cells are labeled in the region of craniofacial mesenchyme adjacent to 
trabeculae (Fig. 17D, H). Similarly to Gpr35a, the kidney is also strongly labeled (Fig. 17G). 
Besides that, expression is also detected in vagal ganglion (Fig. 17A and F). 
 
FFAR2c 
FFAR2c are broadly expressed in the brain (Appx. 7.2D). The expression is distributing from 
telencephalon to rhombencephalon (A, D-G). FFAR2c is strongly labeled in Merkel’s cartilage 













Analysis of p2y5  expression in  5dpf larval by whole mount in situ hybridization. Panel (A-C), 
whole mount, (D-G, M) coronal and (H-L) transverse sections after hybridization. A) Lateral view 
shows expression in brain including midbrain hindbrain boundary, trigeminal ganglion and 
branchial arches; (B) Dorsal view shows expression in ventricular region of telencephalon, 
diencephalon and rhombencephalon, trigeminal ganglion and midbrain hindbrain boundary; (C) 
Ventral view shows expression in Meckel’s cartilage, branchial arches and pectoral fin; In the 
central nervous system, expression is detected in the ventricular region of telencephalon (D, F, 
H), diencephalon (D, F) and rhombencephalon (E, K) in the brain and spinal cord (L); Trigeminal 
ganglion which is a component of menchanosensory system is labeled (J); In auditory system, 
expression is detected in octaval ganglion and otic vesicle (F, K). Expression is also detected in 
branchial arches (G), pectoral fin (F and G), craniofacial mesenchyme  and ciliary marginal zone 
of the eye (H-I); (O) Sense riboprobe. 
 
 
Figure 14 | Expression of p2y10 in brain and ciliary marginal zone of the eye. 
Analysis of p2y10 expression in  5dpf larval by whole mount in situ hybridization. Panel (A-C), 
whole mount, (D) coronal and (E-G) transverse sections after hybridization. A) Lateral view 
shows expression in brain including midbrain hindbrain boundary, vagal ganglion and branchial 
arches; (B) Dorsal view shows expression in midbrain hindbrain boundary; (C) Ventral view 
shows expression in vagal ganglion and branchial arches; In the brain, the expression is 
detected in the dorsal of pallium, midbrain hindbrain boundary (E), dorsal of medulla oblongata 
and vagal ganglion (F);  Expression is also detected in pharynx (D), craniofacial mesenchyme, 








Analysis of p2yl-6 expression in 5dpf larval by whole mount in situ hybridization. Panel (A-E), 
whole mount, (F-J) coronal and (K-O) transverse sections after hybridization. A) Lateral view 
shows expression midbrain hindbrain boundary and vagal ganglion; (B) Dorsal view shows 
expression in ventricular region of telencephalon, diencephalon, mesencephalon and 
rhombencephalon, and midbrain hindbrain boundary; (C-D) Ventral view shows expression in 
mandibular arches, ceratohyal, branchial arches and Meckel’s cartilage; (E) Dorsal lateral view 
shows pectoral fin is labeled; In the brain, expression is detected in the ventricular region of 
telencephalon (B, F, K), diencephalon (B, F, L), mesencephalon (L-M) and rhombencephalon 
(F, M); Expression is detected in pharyngeal branches that includes mandibular aches (C, H), 
palatoquadrate (K), ceratohyal  (C) and branchial arhes (G-I); Several cells in optic vesicle (J) 
and craniofacial mesenchyme (K) are also labeled; Expression is also detected in vagal 







Figure 16 | Expression of Gpr35a in brain, vagal ganglion, pharyngeal arches, kidney and 
ciliary marginal zone in the eye. 
Analysis of Gpr35a  expression in 5dpf larval by whole mount in situ hybridization. Panel (A-C), 
whole mount, (D-H) transverse and (I-K) coronal sections after hybridization. A) Lateral view 
shows expression in the brain and optic vesicle; (B) Dorsal view shows expression in Merkel’s 
cartilage, ciliary marginal zone in the eye and brain; (C) Ventral view shows expression in 
Merkel’s artilage, ceratohyal and branchial arches. In the brain, expression is distributed from 
anterior region of subpallium to dorsal of medulla oblongata (D-G, I); Expression is detected in 
palatoquadrate and ciliary marginal zone of the eye (D), otic vesicle (I), vagal ganglion (G) and 





Figure 17 | Expression of Gpr35c in brain, vagal ganglion, pharyngeal arches and kidney.  
Analysis of Gpr35c expression in 5dpf larval by whole mount in situ hybridization. Panel (A-C), 
whole mount, (D-E, H) coronal and (F-G) transverse sections after hybridization. A) Lateral view 
shows expression in brain and vagal ganglion; (B) Dorsal view shows expression in 
mesencephalon midbrain hindbrain boundary, rhombencephalon and Meckel’s cartilage; (C) 
Ventral view shows expression in mandibular arches, ceratohyal and  branchial arches; In the 
brain, the expression is distributed from anterior of pallium to medulla oblongata (D, H); 











2.12   Broad expression of P2Y genes in adult olfactory epithelium 
Although P2Y genes are not detected in the olfactory organ in 5dpf larval, the expression is 
detected in adult olfactory epithelium. The expressions are detected both in sensory and non-
sensory regions (Fig. 19). This is in contrast with the expression of established olfactory 
receptor genes that are restricted to the sensory regions. In the sensory regions, P2Y genes are 
expressed throughout the lamellae, i.e. also in the regions where the known three types of 
olfactory sensory neurons are positioned. Hence, there is a possibility that P2Y genes are 
expressed in the olfactory sensory neurons or sustentacular cells. The non-sensory regions 
contain goblet cells, ciliated non-sensory cells with microridges which involve in regulation of 
water flow into olfactory epithelium. In addition, goblet cells secrete mucus upon interaction with 
stimuli. The secretion of mucus might influence odor detection due to the changes in mucus 















Figure 18 | Expression of P2Y genes in zebrafish olfactory epithelium. 
(A) Schematic representation of the localization of the olfactory epithelium followed by a drawing 
of a horizontal section of olfactory epithelium (lamellae are cut perpendicular to their flat 
surface) and finally an enlargement of two lamellae. The central blue-coloured are in the 
lamellae indicates the location of sensory neuroepithelium; gray areas and thin dotted line, 
basal lamina; black dots and asterisk, lumen (Weth et al., 1996). (B) In situ hybridization with 
p2y5, p2y10, p2yl-6 and p2yl-10a in horizontal sections of olfactory epithelium. Panel a, b, d, e, g, 
h, j and k are hybridizations with antisense probes whereas panel c, f and I are with sense 
probes. Panel b, e, h and k show higher magnification of the lamellae. The black asterisks 




3.   DISCUSSION 
 
3.1   P2Y receptors originate early in vertebrate lineage  
Stimulation of ATP increased the rate of output of contractile vacuoles in Amoeba (Pothier et al., 
1984, 1987; Couillard, 1986) and Paramecium (Organ et al., 1968) suggesting the emergence 
of purinergic signaling early in evolution. Electrophysiology methods had been used to 
demonstrate the presence of ATP receptors in invertebrates (Burnstock, 1996) but no receptors 
has been cloned until recently. The cloning of a P2X receptor in both Dictyostelium discoideum 
and Schistosoma mansoni (Agboh et al., 2004; Fountain et al., 2007) for the first time identified 
receptors involve in mediating purinergic signaling in invertebrates. However, P2Y genes were 
not detected in invertebrate species (Fredriksson and Schioth, 2005). The absence of P2Y 
genes in invertebrates was confirmed by our database mining. Therefore, it is reasonable to 
suggest that P2Y receptors arise in the vertebrate lineage and in fact after the split between 
chordates and vertebrates.  
 
3.2   Low resolution of basal taxa in phylogenetic analysis 
In all the methods used in P2Y tree construction the early sub-branching possessed a low 
bootstrap value, which does not allow to pinpoint the early evolution with any degree of 
certainty. Moreover, these low bootstrap values suggest that these genes have diverged in an 
extremely short period (Fredriksson et al., 2003). P2Y genes emerged presumably around 550 
MYA based on the existence of lamprey homologues. Functional P2Y are phylogenetically 
divided into two groups; group I encompasses P2Y1, P2Y2, P2Y4, P2Y6 and P2Y11 whereas 
group II members includes P2Y12, P2Y13 and P2Y14. In zebrafish, amino acid identity within 
members of the group varied between 27-46%. The orthologues generally have a higher identity 
in pairwise comparisons (>60%). Furthermore, the amino acid identity between two groups 
varied between 20-29%. The low percentage of shared identical amino acid implies that P2Y 
genes are very divergent.  
 
In the phylogenetic tree analysis, P2Y genes coalesced with platelet-activating, succinate and 
many orphan receptors. Phylogenetic distances between platelet activating factor receptors and 
P2Y receptors (P2Y12-P2Y14) are very small. In addition, both groups of receptors are involved 
in haematopoiesis (von Kugelgen, 2006) suggesting that the outgoup of platelet activating factor 
receptors shared a common ancestor with P2Y receptors and underwent subfunctionalization 




3.3   Evolutionary dynamics of the P2Y family in fish 
The basal lineages (lamprey and shark) have fewer genes than the higher species reflecting the 
continuous expansion of the P2Y family. However, the coarse composition of the family was 
already established in the common ancestor of shark and bony fish, i.e. more than 530 million 
years (MYA) ago, since most of the teleost subclades contain an orthologous shark gene. More 
recent gene expansions have occurred in both the teleost and the tetrapod lineage, with a 
preponderance in the teleost lineage. As a result, Sarcopterygii lineage tends to have only half 
the number of genes compared with Actinopterygii lineage. Mostly, these gene expansions 
appear to have been local gene duplications. Teleost species have a higher number of genes 
than tetrapods due to whole genome duplication that occurred 302-404 MYA (Semon and 
Wolfe, 2007), at the base of the teleost fish lineage. However, this whole genome duplication 
does not appear to explain the increased number of teleost fish P2Y family members, because it 
should not lead to local duplication events. The smaller size of the P2Y family in pufferfish may 
be related to the genome compaction observed in this genus. 
 
Gene duplication affects the functional relationship between duplicated gene copies. Duplicated 
genes can either i) lose the gene function by pseudogene formation, ii) diversify gene function 
by neofunctionalization or iii) partition the ancestral gene function by subfunctionalization (Lynch 
and Force, 2000; Lynch et al., 2001). My observation is that mostly the duplicated genes are 
conserved between the distantly related zebrafish and pufferfish, which argues against 
possibility i) and supports the interpretation that the duplicated genes are likely to be functional. 
Paralogues Gpr35a and Gpr35c shared a similar expression pattern which is consistent with the 
subfunctionalization model of gene duplication in teleost (Lister et al., 2001; McClintock et al., 
2002; Yu et al., 2003). However, a decisive answer to this question will have to await functional 
studies of these genes.   
 
Species-specific duplication occurred in zebrafish and generated an additional six paralogues 
(p2yl-13) in the major cluster in chromosome 15. These genes were created through local 
tandem duplication from adjacent genes. This tandem duplication is rather recent based on the 
close similarity to the adjacent genes in the chromosome. Other species did not undergo the 
equal rate of expansion in this cluster. The occurrence of gene expansion in this particular 
cluster might be a regulatory mechanism to enhance the fitness of the genes. In clustered 
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genes, genes may confer selective benefits via their ability to be co-regulated and co-amplified 
(Schoneberg et al., 2007). 
 
P2Y orthologues are found in tetrapods, bony and cartilaginous fishes. However, not all 
members appear to be present in all vertebrate classes. Orthologues of p2yl-3 and p2yl-4 are 
not found in the human genome. These genes appear to have been lost in the mammalian 
lineage. Likewise, orthologues of p2y15, p2yl-6, Gpr65 and CysLtr2 are not found in the frog 
genome. The selective loss of some of the receptors in some of the species implies that these 
receptors are less important in the corresponding species. It may be compensated by some 
other receptors or mechanisms to ensure that the biological system is not affected. Gpr87 is 
found in elephant shark, frog and human, but is absent in the teleost lineage. Since an 
orthologue of Gpr87 is found in elephant shark, the loss of Gpr87 must have taken place after 
the split of Actinopterygii and Sarcopterygii lineage, affecting only the Actinopterygii lineage. 
The gene loss might occur as a mechanism to eradicate mutated or non-functional genes from 
the genome.  
 
P2Y genes in the teleost lineage generally are slow-evolving, as evidenced by a strong negative 
selection. Negative selection removes disadvantageous mutations that are deleterious. 
Interestingly, subfamilies p2yl-3, p2yl-13, p2y15 and Gpr35 display a higher than average dN/dS 
ratio. Most of these subfamilies comprise duplicated genes. Gene duplication often precedes 
elevated evolutionary rates due to positive selection or relaxed selective constraints (Ohta, 
1993). The increased in non-synonymous substitution rates in duplicate genes might be due to 
the fact that duplicates genes have to undergo functional specialization in order to be 
maintained in the genome. Hence, groups with duplicates may be under relaxed purifying 
selection.  
 
A positively selected site in each of the p2yl-4 and p2yl-7 subfamilies is not located in the ligand 
binding domain of the receptor. This may indicate that the ligand binding domain remains 
unaffected, however, we cannot exclude the possibility that the positive selected sites could 
affect the conformational changes of the receptor to its active stage. All P2Y receptors possess 
four cysteine residues in the extracellular loops and N-teminal region to form two disulfide 
bridges. Mutation studies on cysteine residue in EC1 and EC2 in human P2Y1 established that 
the disulfide bridge between cysteine residues in EC1 and EC2 is critical for proper trafficking of 
the human P2Y1 receptor to the cell surface. Mutation studies on the second disulfide bridge 
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between cysteine residues of N-terminal domain and EL3 displayed impaired response of the 
mutated receptors. This second disulfide bridge covalently constrains the helical bundle in a 
circular arrangement (Hoffman et al., 1999).  Members of p2yl-7a subfamily maintained the 
conserved cysteine in N-terminal domain. In contrast, in the p2yl-7b Subfamily the conserved 
cysteine residue is replaced by leucine, phenylalanine or serine (Fig. 5). The replacement of the 
conserved cysteine in all members of p2yl-7b will disrupt the formation of disulfide bridge 
between N-terminal domain and EL3 and therefore influence the proper functioning of the 
receptor. It is interesting to note that the amino acid position directly prior to the conserved 
cysteine in N-terminal domain in all members of p2yl-7b undergoes non-synonymous 
substitution. The positive selection in this site might be attributed to the compensation of the 
loss of conserved cysteine residue in pyl-7b members.  
 
Twenty-three out of sixty-three genes are singletons whereas the remaining genes appear as 
small clusters in the zebrafish genome. The majority of the clusters comprises just two genes 
and only one case exists, in which 10 genes are positioned in a single cluster in chromosome 
15. The close arrangement of related genes is the evidence of gene development via gene 
duplication (Fredriksson, 2003). The clustering of almost two thirds of the total P2Y genes 
suggests that most P2Y genes arise from duplication event. The clustering of P2Y genes in the 
genome is also perceived in the genome of stickleback, medaka and tetraodon (data not 
shown). 
 
The conserved synteny of P2Y genes (p2yl-12, P2Y14, Gpr87, P2Y13, and P2Y12) in human and 
elephant shark is also extended to the teleost lineage. Comparison of teleost fish genome 
(zebrafish, stickleback, medaka and tetraodon) and human genome in this locus indicates that 
teleost lineage possess additional genes. The genes are most likely incorporated into the locus 
via tandem gene duplications. Teleost genome undergoes a high level of rearrangements as 
reflected by the less-than-perfect synteny observed (Fig. 8a). Syntenic genes are scattered to a 
different numbers of chromosome depending on the fish species implying that the teleost 
genome is dynamic and susceptible to rearrangements.  
 
3.4   Intron gains in the P2Y genes family 
In contrast with mammalian P2Y genes which are mostly composed of monoexonic (>90%) 
structure, a quarter of analysed teleost P2Y genes contain up to five introns. The ancestral 
genomic structure appears to be monoexonic, supported by the presence of intronless 
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orthologues of the analysed genes in both lamprey and shark. The increased frequency of 
accumulated introns in teleost implies that bony fish is susceptible to intron-gain and this event 
is most likely to occur after the split of Sarcopterygii and Actinopterygii lineage. The 
accumulated introns in Actinopterygii lineage but not Chondrichthyes (ancestor of Actinopterygii) 
support the introns-late theory of intron gain in P2Y genes.  
 
The gene structure of  P2Y genes in teleost lineage is not well–conserved during evolution. The 
multiexonic genes are scattered in the phylogenetic tree suggesting the intron-gain event is a 
random process. Some subfamilies are more susceptible to accumulate introns (e.g. P2Y13) 
than others (e.g. P2Y1). Even within a subfamily, not all orthologues acquire introns (e.g. P2Y2) 
and the situation became more complicated with the number of acquired introns varying 
between species (e.g. p2y10).  
 
Further analysis of the exon/intron border of P2Y genes displayed a total of 50 independent 
intron gain events in the teleost lineage. Twenty-two events occurred only in one fish species, 
i.e. late in evolution, after all five teleost species analysed here had separated from each other, 
five events are seen in 2 fish species, twelve events involved in 3 fish species, eight events 
involved in 4 fish species and only 3 events that showed all five fish species acquired introns. 
Zebrafish exhibited the lowest number of intron gains, only eight events. The frequency for the 
other four fish species, all of them Neoteleostei, is at least 2-fold higher than zebrafish. The 
results imply that neoteleost species have a higher tendency to acquire introns than zebrafish 
which is evolutionary more ancient than neoteleost species. It is also further indicates that some 
introns in P2Y genes arose  recently.  
 
It is interesting to note that all the members of p2yl-13 clade accumulated introns in the gene. It 
had been mentioned previously that this cluster has arisen through tandem duplications. The 
intron gain in this cluster might be a consequence of the tandem duplications. Venkatesh et al. 
has shown that tandem duplication of an exon or gene can give rise to novel introns through the 
use of cryptic splice sites (1999). 
 
During the whole vertebrate evolution, only three events of intron loss occurred. In one of the 
cases, intron loss is only observed in one of the gene in the clade. All the teleost members in 
p2y7a clade possess two introns in their gene structure. Stickleback has two homologues in 
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p2y7a clade, Ga_p2y7a1 and Ga_p2y7a2. Ga_p2y7a2 maintained twon-introns structure but 
Ga_p2y7a1 lost one of the intron during the evolution.   
 
Neoteleost (stickleback, medaka, tetraodon and fugu) genome size is between 385-1000Mb 
whereas zebrafish possess a larger genome at 1700Mb. Smaller genomes tend to have fewer 
introns due to the selection of genes that can produce proteins quickly in response to external 
stimuli (Jeffares et al., 2006). However, the findings for the P2Y family are not consistent with 
this notion, for so far unknown reasons.  
 
3.5   Potential roles of P2Y receptors in zebrafish 
Despite the fact that P2Y receptors had been identified more than 20 years ago, most of the 
studies were focused on pharmacological research of mammalian receptors. Only a few studies 
have been carried out to investigate the expression and function of P2Y receptors in embryonic 
development (Meyer et al., 1999 and Cheung et al., 2003). Not much is known about the 
functional role of these receptors in zebrafish although P2Y1 has been shown to express in 
zebrafish thrombocytes (Gregory and Jagadeeswaran, 2002).  
 
P2Y receptors are broadly expressed in many adult tissues and major organs as analysed by 
RT-PCR, suggesting that these genes play many functions in the organism. RT-PCR results 
showed the expression of P2Y receptors in olfactory epithelium of adult zebrafish. Conversely, 
no labeling is detected in olfactory organ in 5 dpf larval zebrafish suggesting that these 
receptors begin to be expressed later in the development. Most of the analysed P2Y receptors 
show redundant expression in brain, pharyngeal branches and otic vesicle in 5 dpf larval. The 
redundancy in expression could imply that these receptors are working in parallel with each 
other. The expression pattern of P2Y genes in central and peripheral nervous system, 
pharyngeal arches, otic vesicle, pectoral fin and kidney is consistent with the hypothesis that 
purinergic signaling regulates proliferation and differentiation processes in larval development. 
 
Expression of P2Y receptors are detected in several proliferative zones in the brain. In the 
forebrain, expression is detected in ventricular zones in telencephalon and diencephalon, and 
habenula. Likewise in the mid- and hindbrain, expression is detected in midbrain hindbrain 
boundary (MHB), ventricular zones in hindbrain extending to spinal cord and ciliary marginal 
zone in the retina. The progenitor cells reside in these zones that generate neuron and glia 
cells. In fish, within the ciliary marginal zone (CMZ) proliferating cells are found throughout life to 
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support the continous growth and enlargement of the retina (Raymond et al., 2006). Neural 
progenitor cells secrete purine nucleotides. Secreted nucleotides activate P2Y receptors to 
mobilize intracellular calcium and suppress the differentiation into neurons and glia cells. The 
addition of antagonists promotes differentiation and inhibits progenitor cell expansion (Lin et al., 
2007). Therefore, P2Y1, p2y5 and p2y10 have the potential to play a role in regulating neural 
progenitor cell expansion and neurogenesis in zebrafish.  
 
Nucleotides are one of the feeding cues in fish. Stimulation of taste buds with taste stimuli will 
induce Type II cells to release ATP, a neurotransmitter. Subsequently, nucleotide receptors, i.e. 
P2X and P2Y receptors are activated to mediate signaling cascade between taste buds and 
afferent taste fibers (Kataoka et al., 2004 and Yang et al., 2008). In fish, mandibular and 
branchial arches develop into jaw and gills respectively. Taste bud primordia are present on the 
lips, mouth, oropharyngeal cavity and gill arches after 4-5 dpf in zebrafish (Hansen et al., 2002). 
The expression of P2Y receptors are detected in branchial arches, pharynx and Merkel’s 
cartilage in which taste bud primordia may develop. Hence, it is conceivable that these P2Y 
receptors may be involved in taste signaling in zebrafish.   
 
P2Y1 and P2Y4 receptors are involved in mediating pain transmission in rat. The receptors are 
expressed in dorsal root, nodose and trigeminal ganglion (Ruan and Burnstock, 2003), 
responsible for sensation in the body, heart, larynx, lungs, alimentary tract and face. On the 
contrary, zebrafish P2Y1 did not have any expression in any of these tissues in 5dpf larval. This 
might be due to the late onset as the expression was observed in adult rats. However, 
transcripts of another P2Y gene, p2y5 are detected very strongly in trigeminal ganglion in 
zebrafish larval, indicating that this receptor plays an early role in mediating facial sensation in 
zebrafish. Possibly, functional roles are fluid within the P2Y family, and orthologues do not 
necessarily fulfil the same roles in different species. 
 
Nucleotide signaling in the inner ear is mediated by the hair cells which function as function as 
mechnosensory transducer that relay signals to brain (Haddon and Lewis, 1996).  P2Y regulate 
the electrical gradient via marginal cells of stria vascularis and vestibular dark cells (Houseley, 
1998). The labeling of epidermal lining of otic vesicle by P2Y receptors suggests that P2Y 





4.   Conclusion and outlook 
 
A thorough phylogenetic analysis of the P2Y receptor family resulted in establishing 38 clades 
within the family. In most cases, clades correspond to orthologues of a single gene, sometimes 
they encompass recently duplicated paralogues. Three clades are only present in teleosts, not 
in tetrapods, implying gene gains early in the teleost lineage. Teleost families contain up to 
twofold the gene number than mammalian families, mainly as a consequence of local gene 
duplications in the teleost lineage, especially in zebrafish, which has the largest gene family with 
68 genes. The P2Y receptor repertoire also is shaped to some extent by gene losses, two in 
humans and one in teleosts. Despite this evolutionary dynamic and some rearrangements in the 
genome, a rough synteny of genomic positions is observed for two clusters of P2Y genes from 
cartilaginous to teleost fish to human, presumably reflecting the functional importance of these 
genes. The presence of P2Y homologues in shark and even in lamprey, but not in ascidians 
(Ciona) indicates an origin early in vertebrate evolution. 
 
A remarkable feature of the P2Y family is the accumulation of introns in many genes. Four 
intron gains are observed in the human lineage, but many more gains and a few intron losses 
occur in the teleost lineage. Some intron gain events even occured within the pufferfish genus, 
i.e. less than 30 million years ago. Taken together, P2Y genes show a remarkable evolutionary 
versatility suggesting a correspondingly dynamic evolution of function in this family. 
 
P2Y genes are broadly expressed especially in the proliferative zone of the brain during 
development, supporting the importance of purinergic signaling in the development of central 
nervous system. Most of the genes showed redundancy in expression pattern indicating that 
these receptors are working in parallel with each other. All P2Y genes analysed are ubiquitously 
expressed in the adult olfactory epithelium, both in sensory and non-sensory regions. This 
expression pattern does not suggest an olfactory function for P2Y receptors, but it does not 
exclude it either. Further experiments need to be conducted with cell markers in order to identify 
the population of cells that expresses P2Y genes (olfactory sensory neurons, sustentacular 
cells, globular cells, nonsensory ciliated cells). If an expression in olfactory receptor neurons 
can be shown, nucleotide binding of heterologously expressed receptors should be attempted, 





5.   MATERIALS AND METHODS 
 
5.1  Materials 
5.1.1 Fish Strains 
The wild-type strains used were Tü/Tü (MPI, Tübingen) and Ab/Tü  
 
5.1.2 Bacterial Strain 
Escherichia coli DH5α bacterial strain was used in transformation.  
 
5.1.3 Plasticware 
All disposable plasticware such as 15 ml and 50 ml Falcon tubes, 6-, 24-, 48-, 96-well plates, 
petri dishes in various sizes were from BD or Castor, purchased from Fisher Scientific or BD 
biosciences. 96-well plates Polyfiltronics for colony PCR were from Whatman (supplied by 
Fisher Scientific), 0.2 ml PCR tubes and sterile pipette tips were from M_P supplied by Fisher 
Scientific. Non-sterile pipette tips were supplied by LaFontaine (Forst/Bruchsal) and Labomedic 
(Bonn). 
 
5.1.4 Technical Equipments 
Unless stated otherwise, general lab equipment was used for the molecular and cell biology 
techniques, including – balances, centrifuges, electrophoresis equipment, heating blocks and 
plates, hybridization and incubation ovens, micropipettes, PCR and gradient thermocyclers, pH 
meter, shakers, sterile hood, UV transilluminator, vortexes and waterbaths. Fresh frozen 
sections were obtained using the Cryostat CM 1900 (Leica). A Nikon SMZ-U binocular 
microscope equipped with Nikon CoolPix 950 digital camera attached was used to document 
whole mount images. A Zeiss AxioVert microscope with an attached Diagnostic Instruments 
Spot-RT camera was used to document non-fluorescent images. A fluorescent microscope 
Zeiss Axioplan I Imaging equipped with Apotome and HRm AxioCam (Zeiss, Germany) was 
used to document fluorescent images of tissue in sections. 
 
5.1.5 Chemicals 
All chemicals, if not noted otherwise, were purchased from Ambion (Austin, USA), Amersham 
Pharmacia Biotech (Freiburg), Applichem (Darmstadt), JTBaker supplied by Fisher Scientific 
(Schwerte), Biozym (Hessisch Oldendorf), Calbiochem (Darmstadt), Difco (Detroit, USA), Fluka 
(Neu-Ulm), Merck (Darmstadt), Molecular Probes (Leiden, NL), Roth (Karlsruhe), Serva 
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(Heidelberg), Sigma (Deisenhofen), Roche (Mannheim, Germany) or  Invitrogen (Karlsruhe, 
Germany) unless stated otherwise. 
  
5.1.5.1  Chemicals and Solutions 
Solutions were prepared with didistilled water. Solutions were autoclaved for 20 min at 121 bar 
or filter sterilized (0.2-0.45 µm pore diameter). Glassware was autoclaved and oven baked for 2 
h at 180°C. For RNA-work, solutions and water were treated with 0.1% diethylpyrocarbonate 
(DEPC), shaked vigorously and mixed for about 20 min on a magnetic stirrer to bring the DEPC 
into solution. The solutions were then autoclaved to remove any trace of DEPC. Tris buffers 
cannot be treated with DEPC because it reacts with primary amines. DEPC decomposes rapidly 
into CO2 and ethanol in the presence of Tris buffers. Therefore, Tris buffers were prepared by 
using water that has been treated with DEPC first. Most of the standard stock solutions like 
EDTA, Tris, TAE, TBE, TE, PBS, SDS, SSC, NaOAc, and culture media like LB and SOC were 
prepared as described in (Sambrook J 1989). All solutions used are named in the text. 
 
E3 embryo media 5mM NaCl, 0.17mM KCl, 0.33mM CaCl2, 0.33mM MgSO4, 5-
5% Methylene blue 
Hyb+ solution (whole mount) 50% deionized formamide, 5X SSC, 0.1% Tween 20, 0.5mg/ml 
torula yeast RNA, 50µg/ml heparin adjusted to pH6.0 with citric 
acid 
Hyb- solution (whole mount) 50% deionized formamide, 5X SSC 
Blocking solution (whole mount) 2% of heat-inactivated sheep serum  and 2% BSA in PBST 
Hyb solution (section) 50% deionized formamide, 5X SSC, 0.4mg/ml torula yeast 
RNA, 0.1mg/ml baker’s yeast RNA, 5X Denhardt’s solution 
Blocking solution (section) 0.5% blocking reagent (Roche) in MABS 
MABS 150mM NaCl, 50mM maleic acid, pH 7.5 
PBS 137mM NaCl, 2.7mM KCl, 4.3mM Na2HPO4, 1.47mM KH2PO4, 
pH7.4 
PBT 0.1% Tween 20 in PBS 







5.1.6 Molecular Biological Reagents 
All used restriction enzymes were purchased from New England Biolabs (NEB). DNA 
polymerases (taq and reverse transcriptase) and DNA ladder were purchased from Bioline. 
DNA ligase and RNA polymerases were purchased from Fermentas and Roche respectively. 
RNaseA and proteinase K were purchased either form Sigma or Roche Biochemicals 
(Mannheim). 
 
5.1.6.1  Molecular Biological Kit  
Name of the kit Company Application 
QIAEX II Gel extraction kit Qiagen Extraction of DNA from gel 
QIAquick PCR purification kit Qiagen Purification of PCR product 
QIAGEN PCR cloning kit Qiagen Cloning of DNA fragment 
RNeasy Mini kit Qiagen Purification of total RNA 
DIG RNA labeling mix Roche Diagnostics Labeling of riboprobe with DIG 
Biotin RNA labeling mix Roche Diagnostics Labeling of riboprobe with biotin 
 
5.1.6.2  Cloning Vector  
Cloning vector Company 
pDrive Qiagen 
 
5.1.6.3  Oligonucleotide Primers 
Oligonucleotide primers were purchased from Operon (Cologne) or Invitrogen Life 
Technologies. The primers were dissolved at a standard concentration of 50mM. Working 
dilutions were prepared at a concentration of 5mM and stored at -20°C. Primers were used for 
sequencing, cloning, and preparation of probes via the addition of T3-RNA polymerase binding 
site. All used primers are listed as below:'_ 
• M13-Fwd, GTAAAACGACGGCCAGT, 
• M13-Rev, AACAGCTATGACCATG, 
• T3, TATTAACCCTCACTAAAGGGAA, 




• Dr actin-Rev, AGCGGTTCCCATCTCCTG,  
• Dr p2y1-Fwd, ATGACAGCGGAGTTTAATAACCTG,  
• Dr p2y1-Rev, TCACATGCGGTTTTCACCGT, 
• Dr p2y4-Fwd, ATGCCGATGTCTTCGAAGGA, 
• Dr p2y4-Rev, CTAGAGTCTCGAATCACTGC, 
• Dr p2y5-Fwd, ATGTACAATACAAGTCTTGAGA, 
• Dr p2y5-Rev, TCATACGTGGGACTCATTGTGA 
• Dr p2y5-Fwd, ATGACATCCATGAATACATC, 
• Dr p2y5-Rev, TCATTCCTTATATGAAGATG, 
• Dr p2yl-6-Fwd, TCATACGTGGGACTCATTGTGA, 
• Dr p2yl-6-Rev, TTATTGTTCCAAACTATTCAAA, 
• Dr p2yl-11a-Fwd, ATGAACAACTATTCTCAAAA, 
• Dr p2yl-11a-Rev, TTATTTGATTATTATTGTTG, 
• Dr Gpr35b-Fwd, ATGTCCAACTGCACGCTCAA, 
• Dr Gpr35b-Rev, TTAAGACTTGCCATCAGAAT, 
• Dr Gpr35c-Fwd, ATGAACTCCTCCAACTCATCGA, 
• Dr Gpr35c-Rev, TTAAGTAAAACCAGTATCCACA, 
 
5.1.6.4  Antibodies 
Name Source Working dilution 
Anti-DIG antibody Roche Diagnostics 1:5000 
 
5.1.6.5  Dyes, Substrates, Embedding Media and Counterstains 
Types Component  Source 



















5.2.1 Embryo maintenance 
Adult zebrafish (Danio rerio) were kept in group tanks at a day/night rhythm of 14/5 h at a water 
temperature of 28°C and fed daily of dry flake foods and brine shrimp (artemia; 
Brustmann,Oestrich-Winkel). The aquaria were filled with a one-to-one mixture of demineralized 
water and tap water. Zebrafish embryos and larvae were kept in petri dishes at a density of 
about 50 embryos/petri dish in E3 embryo medium at 28°C without feeding for five days. 
Afterwards, they were raised in 2l containers. They were fed with special food for fish larvae 
until the age of two weeks (TetraMin Mini, TETRA), followed by artermia afterwards. 
 
In order to elicit a controlled reproductive activity, selected females and males were put into a 
separate tank. Early in the following morning, fertilized eggs were collected and their age was 
determined using the staging criteria of Kimmel et al. (1995). The embryos were then raised and 
collected at 24h intervals for histological and immunohistochemical processing. Embryos fixed 
at a stage older than 24 h postfertilization (hpf) were raised in 2 mM 1-phenyl-2-thiourea (PTU) 
in embryo medium after the epiboly stage (about 12 h) to prevent pigmentation. The embryonic 
and larval stages used for all investigations reported here ranged between one and 21 days 
postfertilization (dpf). 
 
5.2.2 Data mining/Identification of P2Ys gene 
Mammalian P2Y receptors were extracted from National Center for Biology Information protein 
database. Two strategies were employed in the subsequent data mining analysis in seven fish 
species: (1) the algorithm tBLASTN was applied to compare amino-acid query sequences to the 
DNA databases (http://www.ensembl.org’index.html) with a non-stringent cut-off value of 5-5 and 
(2) the automatically orthologue predicted genes predicted in fish species were retrieved from 
query sequences. 
 
Subsequently, the P2Y-like genes are then verified through inclusion criteria. The inclusion 
criteria used were: (1) positioning within the P2Ys clade in phylogenetic analysis; (2) employing 
BLASTP algorithm in the NCBI non-redundant database in which first hits should resulted 
annotated P2Ys or P2Y-like candidate and had a significant E-value; (3) presence of seven 
transmembrane domains (based on consensus of the prediction results obtained by using 
TMHMM at http://www.cbs.dtu.dk/services/TMHMM and TMpred at 
http://www.ch.embnet.org/software/TMPRED_form.html) and (4) CDS length of between 800 to 
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1200bps. Duplicate genes were removed and resulting genes were subjected to the further 
analyses described below. The automatically annotated orthologues of fish P2Y genes in 
Xenopus tropicalis and mammalians were also retrieved and included in subsequent 
phylogenetic analysis.  
 
All contigs containing P2Y receptors BLAST hits were manually collected. ORF finder 
(www.ncbi.nlm.nih.gov/projects/gorf/) and GeneWise (http://www.ebi.ac.uk/Wise2/index.html) 
programs were employed to retrieve the full-length of the sequence. 
 
5.2.3 Phylogenetic analysis 
To infer the relationship of the sequences, phylogenetic analysis of distance-based, maximum 
parsimony and maximum likelihood analyses were performed using Neighbour-Joining (NJ), 
Protpars (MP) and Proml (ML) programs respectively. Olfactory receptors are used as 
outgroups to root the tree. Bootstrap analysis was carried out to measure the robustness of 
branching patterns of the tree.  
 
5.2.3.1  Sequence alignment 
The multiple protein sequences were aligned by using E-NS-I strategy with the default 
parameters in MAFFT version 6 (http://align.bmr.kyushu-u.ac.jp/mafft/online/server/). The 
obtained alignment was then manually refined in MEGA 4, without removing the transmembrane 
regions. Due to the lack of sequence similarity, only short segments of the amino-terminal 
domain and carboxyl-terminal domain were aligned. 
 
5.2.3.2  Neighbour-Joining method 
Neighbour-Joining method was performed using ClustalX with bootstrapping 500 replicates.  
 
5.2.3.3  Maximum parsimony method 
The 387 aligments used were bootstrapped 50 repetitions using SEQBOOT from PHYLIP 3.67 
package. The bootstrapped files were used for calculating maximum parsimony trees with 
Protpars from PHYLIP 3.67 package. The trees were unrooted and calculated using ordinary 






5.2.3.4  Maximum likelihood method 
The 387 aligments used were bootstrapped 50 repetitions using SEQBOOT from PHYLIP 3.67 
package. The bootstrapped files were used for calculating maximum likelihood trees with Proml 
from PHYLIP 3.67 package. The trees were unrooted and calculated using ordinary likelihood.  
Consensus trees were obtained using CONSENSE program of the phylip package.  
 
5.2.4 Evolutionary analysis 
5.2.4.1  Identity and similarity matrix 
Pairwise alignments of the 68 fish P2Y-like amino acid sequences were performed using the 
EMBOSS Pairwise Alignment Algorithm (http://www.ebi.ac.uk/emboss/align/) and both the 
Identity and Similarity values from all the possible comparisons were retrieved and used to 
make the matrix. 
 
5.2.4.2  Sequence logo 
Sequence logos were generated using a web-based program, Weblogo (version 2.8.2) 
developed by (http://weblogo.berkeley.edu/logo.cgi). A logo was generated with the 227 fish 
P2Y amino acid sequences representing full-length ORFs. Sequence alignments were manually 
edited using MEGA 4 (Kumar et al., 2004) and highly divergent pieces between the start codon 
and the beginning of TM1 and 7 amino acids downstream of the conserved Proline (P) in the 
TM7 were trimmed to avoid N- and C-terminal length heterogeneity. This did not affect 
significantly conserved residues. Gap positions present in more than 85% of the sequences 
were deleted completely. 
 
5.2.4.3  dN/dS analysis 
The global dN/dS ratios for the full length ORF of the 227 fish P2Y receptor coding sequences 
were determined using Single Likelihood Ancestor Counting (SLAC) package 
(http://www.datamonkey.org), which implements the Suzuki-Gojobori method (Suzuki and Gojobori, 
1999). The nucleotide alignment was manually edited to match the amino acid alignment used in 
the phylogenetic trees and sequence logo. To make inferences about selective pressure 
(positive and negative selection) on individual codons (sites) within the coding sequence of the 
teleost P2Y genes, the Single Likelihood Ancestor Counting (SLAC) package 
(http://www.datamonkey.org), which implements the Suzuki-Gojobori method (Suzuki and 
Gojobori, 1999), was used. The algorithm is briefly outlined. First, a best-fitting nucleotide 
substitution model was automatically selected by fitting several such substitution models to both 
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the data and a neighbor-joining tree generated from the alignment described above. Taking the 
obtained substitution rates and branch lengths as constant, a codon model was employed to fit 
to the data and a global dN/dS ratio was calculated. Then a codon by codon reconstruction of 
the ancestral sequences was performed using maximum likelihood. Afterwards the expected 
normalized (ES) and observed numbers (EN) of synonymous (NS) and non-synonymous (NN) 
substitutions were calculated for each non-constant site. dN = NN/EN and dS = NS/ES were 
then computed, and if dN < dS (negative selection) or dN > dS (positive selection), a p-value 
derived from a two-tailed extended binomial distribution was used to assess significance. Tests 
on simulated data (S.L.K. Pond and S.D.W. Frost, methods available at 
http://www.datamonkey.org) show that p values equal or smaller than 0.1 identify nearly all true 
positives with a false positive rate generally below the nominal p value; for actual data, the 
number of true positives at a given false positive rate is lower. In the present study, two 
thresholds for significance (0.1 and 0.2) were taken into account in order to identify residues 
potentially involved in odorant-binding activities. 
 
5.2.5 Molecular biology techniques 
5.2.5.1  Cloning of P2Y genes 
5.2.5.1.1 Amplification of P2Y genes 
Putative P2Ys were amplified from cDNA of olfactory epithelium and 5dpf larvae, and genomic 
DNA using the following primers: P2Y1, P2Y4, P2Y5, P2YR6, P2YR8, P2Y5, P2YR13 and 
P2YR17. Twenty-microlitre reaction mixture was assembled (5µl of 2X RedTaq Mix, 1µl each of 
forward and reverse primer, 5ng of template and sterile water). Denaturation of template was 
carried out at 960C for 2 min, followed by 35 cycles of 960C for 30 sec, 580C for 45 sec 720C for 
1 min and a final elongation of 720C for 5 min. The PCR products of the expected sizes were 
excised from agarose gel and cloned into pDrive (Qiagen). 
 
5.2.5.1.2 Gel electrophoresis 
PCR products were loaded on 1% agarose gels containing 0.5µg/ml ethidium bromide in 1X 
TAE buffer and run at 50 V. 
 
5.2.5.1.3 Purification of DNA fragments from agarose gel 
The DNA fragment was purified using Qiagen’s QIAEX II agarose gel extraction kit. The DNA 
band was excised from agarose gel. Three volumes of Buffer QX1 were added to one volume of 
excised gel. Ten-microlitre of QIAEX II was added into the mixture and resuspended by 
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vortexing. The mixture was incubated at 500C for 5 minutes to solubilize the agarose and 
facilitating the binding of the QIAEX II to DNA. The mixture was pelleted through centrifugation 
and washed with Buffer QX1 to remove residual agarose contaminants. Next, the pellet was 
washed twice with Buffer PE. Finally, the pellet was air-dried and the DNA was eluted by 
resuspending the pellet with 5mM Tris-Cl pH8.0. 
 
5.2.5.1.4 Ligation into pDrive cloning vector 
The ligation of PCR products into pDrive cloning vector was carried out using Qiagen’s PCR 
cloning kit. Ligation mixture containing 2µl of PCR product, 2.5µl of ligation master mix and 0.5µl 
pDrive cloning vector was prepared and incubated at 160C for 30 min. After that, the ligation 
mixture was heated at 700C for 5 min to inactivate the enzyme activity.  
 
5.2.5.1.5 Chemical transformation 
One microlitre of ligation mixture was added into a tube of DH5α competent cells and mixed 
gently. The mixture was then incubated on ice for 30 min. Next, the cells were heat-shocked at 
420C in a heating block for 1 min followed by rapid cooling on ice for 1 min. After that, 800µl of 
LB broth was added into the tube and incubated for 1 hour at 370C with shaking at 700rpm.  
Then, the cells were pelleted at 500g for 1 min and resuspended in 50µl of LB broth and plated 
onto LB plate containing ampicillin. Finally the plate was incubated at 370C overnight. 
 
5.2.5.1.6 Plasmid DNA minipreparation 
A single colony was picked from up from agar plate and inoculated into 3ml of LB broth 
containing ampicillin antibiotic. The bacteria were cultured overnight at 370C on a shaker at the 
speed of 180rpm. 
 
About 1.5ml of the overnight culture was transferred into an eppendorf tube and the remaining 
was made up to 5% glycerol stock and stored at –800C. The cells were pelleted by centrifuging 
at 13,000 rpm for 1 min at room temperature. The supernatant was drained and the pellet was 
resuspended by vigorous pipetting or vortexing in 300µl Solution I containing Tris-EDTA-glucose 
buffer (25mM Tris-HCl pH 8.0, 5mM EDTA, 50mM glucose). Then, 300µl of freshly mixed 
Solution II (0.2M NaoH, 1% SDS) was added. The mixture was mixed well by inverting the tube. 
Next, 300µl of Solution III (3M with respect to potassium and 5M with respect to acetate) was 
added and mixed gently by inversion. The cell debris and bacterial genomic DNA was pelleted 
by centrifugation at 13,000 rpm for 5 min at room temperature. The supernatant was transferred 
71 
 
to a fresh tube 0.6 volume of isopropanol was added. The solution was mixed and then 
incubated at –200C for 5 min. The plasmid DNA was pelleted by centrifugation at 13,000 rpm for 
5 min at 40C. The supernatant was discarded and the pellet was washed with 200µl of 70% 
ethanol. The pellet was allowed to air-dry and finally, the pellet was resuspended with 30µl of 
autoclaved distilled water and stored at 40C or –200C. 
 
5.2.5.1.7 Restriction enzyme digestion of plasmid DNA 
Digestions of plasmid DNA were performed using about 200ng of plasmid in 1x restriction 
enzyme digestion buffer and 6U of restriction enzyme in a total volume of 20µl. Digestion 
mixtures were incubated for 1-2 h at the appropriate temperatures as suggested by the 
manufacturer. 
 
5.2.5.1.8 Preparation of glycerol stock 
Glycerol stock was prepared by adding 200µl of sterile 50% glycerol to 800µl bacterial culture. 
The mixture was vortexed to ensure even dispersion of the glycerol and subsequently froze in 
liquid nitrogen. Afterwards, the tube was transferred to -800C for long-term storage. 
 
5.2.5.1.9 DNA sequencing 
DNA sequencing was carried at the core facility of the Institute of Genetics by Rita Lange on an 
ABI Prism 3730 DNA Analyzer (Applied Biosystems, USA).  
 
For each cycle sequencing reaction, the following reagents were added into each tube: 2µl of 
BigDye terminator premix (ABI Prism), 3.2pmol primer, 200-500ng of purified plasmid DNA and 
autoclaved distilled water to a final volume of 5µl. Then, the mixture was mixed and briefly spun 
down. The sequencing profile used was as follows: 40 cycles at 950C for 20 sec, 500C for 15 
sec and 600C for 4 min. The samples were ethanol precipitated and dried thoroughly. The dried 
samples were stored at -20°C in the dark until they were electrophoresed.  
 
Sequence analysis was carried out using BLAST (Basic Local Alignment Search Tool), 
accessed through the Internet (http://www.ncbi.nlm.nih.gov/). Alignments of the sequences with 






5.2.5.2 Expression analysis of P2Ygenes 
5.2.5.2.1 Isolation of total RNA 
Total RNA was extracted from various tissues of the fish: barbel and lips, olfactory epithelium, 
olfactory bulb, eye, brain, grills, heart, liver, intestine, kidney, gonad, spleen and skin. The 
tissues were dissected in ice-cold Phosphate Buffered Saline (PBS) and stored in Buffer RLT 
(RNeasy Mini Kit, Qiagen). The tissue was homogenized using s syringe and needle. The lysate 
was passed through a 20-gauge (0.4mm) needle attached to a sterile plastic syringe for 5-5 
times until a homogenous lysate is achieved. Then, RNA was isolated using RNeasy Mini Kit of 
Qiagen according to manufacturer’s instructions. Next, purified RNA was treated with 4.7U of 
RNase-free DNase  (Promega) for 30 min at 370C to remove contamination of genomic DNA. 
This was followed by phenol/chloroform extraction to remove the added DNAse. RNA was 
precipitated using 0.8M lithium chloride and 2.5 volumes of ice-cold absolute ethanol. 
Precipitation was allowed at -200C for 30 min or at -800C for 5 min. Finally, RNA was pelleted 
and resuspended in the appropriate buffer.  
 
5.2.5.2.2 Synthesis of first-strand DNA 
Total RNA was mixed with 1µl of oligo (dT)12-18 and made up to 11.8µl with DEPC-distilled 
water. The mixture was heated at 700C for 5 min to denature the secondary structure, followed 
by brief rapid cooling on ice.  The contents of the tube were spun down by a brief centrifugation. 
Next, 4µl of 5X first-strand buffer, 2µl of 0.1M DTT, 1µl of 5mM dNTP mix, 1µl of RNaseOUT 
and 0.2µl of Bioscript (200U/µl, Bioline) were added into the mixture and mixed. Subsequently, 
the reaction mixture was incubated at 420C for 50 min. The reaction was inactivated by heating 
at 700C for 15 min. Finally, the mixture was diluted with 30µl of sterile, distilled water and the 
cDNA can be used as a template for amplification in PCR. 
 
5.2.5.2.3 Polymerase chain reaction (PCR) 
The 20µl PCR reaction contained 0.25µl of cDNA, 5µl of 2X RedTaq Mix, 1µl each of 5µM 
forward and reverse primers and distilled water. The thermal cycler regime was as follows: 950C 
for 2 min, followed by 35 cycles of 950C for 30 sec, 580C for 45 sec, 720C for 1 min and a final 
elongation step of 720C for 5 min.  
 
5.2.5.3  In situ hybridization 
In situ hybridisation techniques simultaneously detect and localize specific DNA or RNA 
sequences providing spatial information about their subcellular locations, within small 
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subpopulations of cells in tissue samples. It can identify sites of gene expression and tissue 
distribution of mRNA.  
 
In situ hybridisation begins with the preparation of biological material and the labelling of a 
nucleic acid sequence to form the probe. The labelling of a nucleic acid involves the 
incorporation of either radioactive or non-radioactive marker, which can be detected. Both probe 
and material are denatured to ensure all nucleic acids are single-stranded. Then, under 
controlled experimental conditions, the single-stranded probe anneals or hybridises to its 
complementary single-stranded nuclei acid sequence in the biological material to form a new 
double-stranded molecule that incorporates the labelled marker. Finally, the sites of 
hybridisation are detected and visualized.  
 
5.2.5.3.1 Cryosectioning 
In situ whole-mount embryos were put in TissueTek (MILES, Elkhart, Indiana, USA), oriented 
and frozen at -20°C. The embryo was sectioned at 5µm. Sections were mounted on coated 
Superfrost plus slides and dried for 3 h at 55°C. Sections were mounted with mounting medium 
before viewing under the microscope. 
 
5.2.5.3.2 Probe preparation 
Sense and antisense RNA probes labeled with digoxigenin (DIG)- or biotin-labeled UTP were 
generated by in vitro transcription according to the manufacturer's instructions (Roche 
Diagnostics). After synthesis, the probes were not hydrolyzed into smaller pieces, as this 
treatment leads to elevated background signals. 
 
Template DNA was generated by PCR using insert specific primers that contained T3 
polymerase promoter sequence at the terminal end. Next, the amplified template was purified 
using PCR purification kit (Qiagen). The in vitro transcription reaction was prepared using about 
200-500ng of purified PCR template, transcription buffer and DIG- or biotin-labeling mixture to a 
final concentration of 1x, 4U of T3 RNA Polymerase , 20U of RNAse inhibitor (Roche 
Diagnostics) and top up to final volume of 20µl. The reaction was incubated at 37°C for 2 hours 
and terminated by addition of 2µl of EDTA (200 mM, pH 8.0). The RNA transcript was ethanol 
precipitated and resuspended in 50µl of DEPC-treated H2O. The quality of the probe was 
analyzed through agarose gel electrophoresis. Labeling efficiency was estimated using DIG 
quantification teststrips (Roche Diagnostics). 
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5.2.5.3.3 Preparation of embryos 
Eggs were collected from mating pairs and unfertilized eggs were discarded.  Embryos were 
allowed to develop in regular fish water until the end of gastrulation (5hpf). After that, the fish 
water was replaced with a solution containing 0.0045% 1-phenyl-2-thiourea to prevent 
pigmentation. The solution was replaced everyday until the larvae reached desired age/stage. 
Next, the larvae were fixed in 4% paraformaldehyde (PFA) in 1X PBS overnight at 40C. The 
fixed larvae were then dehydrated in 50% methanol for 15 min at room temperature and finally 
stored at -200C until further use. 
 
5.2.5.3.4 Whole-mount in situ hybridization of embryos 
Whole mount RNA in situ hybridization of zebrafish embryos or larvae was performed following 
the method of Thisse et al., (1993).  
 
On the first day, the larvae went through a serial of rehydration in the following manner: 75% 
methanol: 25% PBS, 50% methanol: 50% PBS and 25% methanol: 75% PBS for 5 minutes 
each. Next, the larvae were washed four times with PBT, 5 mins for each washing. After that, 
the larvae were digested with proteinase K (5µg/ml) for 30 minutes at 370C to increase probe 
permeability into the larvae. The digestion was terminated by incubation in 4% 
paraformaldehyde in 1x PBS for 20 minutes. This was followed by five washings in PBT, 5 
minutes for each washing. Subsequently, prehybridization was performed by incubating the 
larvae in 500µl of hybridization mix at 700C waterbath for 1 hour. After that, the prehybridization 
mix was replaced with hybridization mix containg about 50ng of antisense DIG-labeled RNA 
probe. The hybridization was left overnight (at least 16 hours) in 700C waterbath. 
On the second day, the hybridization buffer was removed and underwent successive washing 
solutions to facilitate solution changes from hybridization buffer to 2x SSC. The serial high 
stringency washings were conducted in the following manner for 15 mins each at 700C: 75%HM-
: 25% 2x SSC, 50%HM-: 50% 2x SSC, 25%HM-: 75% 2x SSC and finally in 2x SSC. In addition, 
two washings of 30 mins each in 0.2x SSC were performed at 700C to remove non-specifically 
hybridised probes. Next, the larvae were progressively washed from 0.2x SSC to PBT at room 
temperature in the following order: 75% 0.2x SSC: 25% PBT, 50% 0.2x SSC: 50% PBT, 25% 
0.2x SSC: 75% PBT and finally in PBT. All the washings were performed for 5 minutes each. 
After that, the larvae were blocked in blocking bluffer containing 2% sheep serum and 2mg/ml 
BSA for 3 to 4 hours in room temperature. Then, the blocking buffer was replaced with antibody 
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solution diluted at 1:5000 in blocking buffer. The incubation with antibody was left overnight with 
slow agitation at 40C. 
 
On the third day, the antibody was removed and the larvae were washed briefly in PBT. This 
was followed by an extensive wash at room temperature, six times, in PBT for 15 mins each 
wqashing. After the last wash, the larvae were incubated at room temperature in alkaline Tris 
buffer (50mM Tris-HCl pH9.5, 50 mM MgCl2, 50mM NaCl, 0.1% Tween 20). After that, the 
larvae were incubated in staining solution containing NBT-BCIP for signal detection. The 
staining reaction is monitored regularly until signal is perceived as sufficient. The, the staining 
reaction is stopped by washing the larvae with stop solution (1x PBS pH5.5, 1mM EDTA, 0.1% 
Tween 20). 
 
5.2.5.3.5 In situ hybridization on sections of olfactory epithelia 
Sections (10 µm) were fixed in 4% paraformaldehyde for 10 min at room temperature. 
Hybridizations were performed overnight at 60°C using standard protocols as previously 
described (Weth et al., 1996). Anti-DIG primary antibody coupled to alkaline phosphatase 
(Roche Molecular Biochemicals) and NBT-BCIP (Roche Molecular Biochemicals) was used for 
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7.   APPENDIX 
 
7.1   List of abbreviations 
A, adenosine 
ADP, adenosine diphosphate 
AMP, adenosine monophosphate 
AP, alkaline phosphatase 
ATP, adenosine triphosphate 
bp, base pairs 
BSA, bovine serum albumin 
cAMP, cyclic adenosine monophosphate 
cDNA, complementary DNA 
CysLtr, cysteine leukotriene 
DEPC, diethylpyrocarbonate 
DIG, digoxigenin 
dpf, days post fertilization 
DNA, deoxyribonucleic acid 
dNTP, deoxyribonucleic triphosphate 
EC, ectracellular domain 
EDTA, ethylenediaminetetraacetic acid 
FFAR, free-fatty acid receptor 
GPCR, G-protein coupled receptor 
HEK 293, human embryonic kidney cells 
IC, intracellular domain 
IPTG, isopropyl-_-D-1-thiogalactopyranoside 
kb, kilo base 
M, molar 




OE, olfactory epithelium 
OB, olfactory bulb 
OMP, olfactory marker protein 
OR, olfactory receptor 
OSN, olfactory sensory neuron 
PBS, phosphate buffered saline 
PCR, polymerase chain reaction 
PFA, paraformaldehyde 




UDP, uridine diphosphate 





7.2   Supplemental figures 
A. Phylogenetic tree of 8 fish species, frog and human 
 
Abbreviations : Pm, lamprey; Cm, elephant shark, Re, little skate; Dr, zebrafish; Ga, stickleback; 
Ol, medaka; Tn, tetraodon; Tr, fugu; Xt, frog; Hs, human; PafR, platelet-activating receptor; 
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B.   P2Y genes accession number and/or IDs, and location 
Species NCBI Ensembl protein database Chromosome/Scaffold Location 
Zebrafish   ENSDARP00000004774 3 53,541,140-53,542,045.  
Zebrafish NP_955900.1 ENSDARP00000032650 2 43,079,372-43,080,946.  
Zebrafish XP_001335235.1 ENSDARP00000045017 14 37,018,669-37,019,712.  
Zebrafish XP_001343519.1 ENSDARP00000058877 1 879,202-880,541.  
Zebrafish XP_694459.1  ENSDARP00000062479 18 25,785,514-25,787,196.  
Zebrafish XP_001341296.1  FGENESH00000078739  24 10,123,808-10,124,984.  
Zebrafish   ENSDARP00000070013 14 37,146,462-37,147,913.  
Zebrafish   ENSDARP00000075538 14 6,365,702-6,366,698.  
Zebrafish   GENSCAN00000023739  5 21,317,494 
Zebrafish   ENSDARP00000081437 5 21,321,347-21,322,297 
Zebrafish   FGENESH00000078957  13 50,798,456-50,842,878.  
Zebrafish XP_001336913.1  FGENESH00000058659  Zv7_NA1868  12,840-19,467.  
Zebrafish   ENSDARP00000087296 Zv7_NA1868  12,636-33,632.  
Zebrafish XP_001336698.1  FGENESH00000071328  1 893,686-894,675 
Zebrafish XP_001339996.1 ENSDARP00000087397 Scaffold Zv7_NA791 33,990-34,949.  
Zebrafish XP_684762.1 ENSDARP00000010296 9 25,044,989-25,046,056.  
Zebrafish NP_001035473.1  ENSDARP00000041935 1 903,492-907,044.  
Zebrafish XP_001342443.1 ENSDARP00000052979 7 17,039,373-17,040,398.  
Zebrafish XP_001346142.1 FGENESH00000084837  23 24,448,733-24,449,707.  
Zebrafish   ENSDARP00000060098 9 25,074,319-25,075,413 
Zebrafish NP_001035080.1 FGENESH00000073641  15 35,485,427-35,486,407.  
Zebrafish XP_693153.1 FGENESH00000073593  6 45,082,130-45,082,981.  
Zebrafish XP_001333765.1 ENSDARP00000069269 2 43,060,465-43,062,121.  
Zebrafish XP_001334713.1  ENSDARP00000075542 14 6,395,616-6,396,587.  
Zebrafish XP_001343355.1 ENSDARP00000080918 18 44,456,810-44,457,877 
Zebrafish XP_687425.2 ENSDARP00000083420 6 19,484,326-19,485,273.  
Zebrafish NP_001073524.1 ENSDARP00000085057 23 13,827,907-13,834,737.  
Zebrafish AAI34132.1 FGENESH00000061740  14 6,408,647-6,419,175.  
Zebrafish XP_700330.1 FGENESH00000066244  18 1,637,660-1,638,214 
Zebrafish XP_691569.2  FGENESH00000071330  15 42,775,008-42,777,576.  
Zebrafish XP_697876.2 ENSDARP00000044742 9 23,293,650-23,294,480.  
Zebrafish XP_001342372.1 ENSDARP00000062129 17 33,899,631-33,901,492.  
Zebrafish   ENSDARP00000068982 1 33,627,665-33,631,029.  
Zebrafish XP_001332886.1  FGENESH00000058248  10 13,607,347-13,608,423.  
Zebrafish   GENSCAN00000005772  5 21,317,594-21,318,487 
Zebrafish   FGENESH00000070496  7 17,426,371-17,428,125.  
Zebrafish   FGENESH00000061858  14 6,499,904-6,500,887 
Zebrafish XP_001340065.1  ENSDARP00000087396 18 1,659202-1,660,173 
Zebrafish XP_692215.1 FGENESH00000051734  15 25,619,485-25,620,579 
Zebrafish   ENSDARP00000062041 17 37,840,794-37,841,684.  
88 
 
Species NCBI Ensembl protein database Chromosome/Scaffold Location 
Zebrafish   ENSDARP00000084735 15 42,665,690-42,690,969.  
Zebrafish   ENSDARP00000067542 17 2,870,988-2,872,004.  
Zebrafish   ENSDARP00000030390 17 38,878,390-38,879,292.  
Zebrafish NM_001025547.1  ENSDARP00000063752 20 18,442,740-18,449,712.  
Zebrafish XP_686786.2 FGENESH00000066881  5 34,052,650-34,054,470.  
Zebrafish   ENSDARP00000072403 9 28,958,014-28,960,102.  
Zebrafish   ENSDARP00000079157 14 41,893,740-41,894,729 
Zebrafish   ENSDARP00000086767 Zv7_NA117    
Zebrafish XP_001342441.1 GENSCAN00000008806  6 39,411,564-39,412,598.  
Zebrafish NP_001076364.1  GENSCAN00000015928  19 8,175,835-8,176,635.  
Zebrafish NP_898896.1  ENSDARP00000007507 17 2,893,697-2,894,776.  
Zebrafish   ENSDARP00000069332 Zv7_NA992    
Zebrafish   ENSDARP00000078231 16 50,292,613-50,293,762.  
Zebrafish   ENSDARP00000075859 19 8,189,303-8,190,178.  
Zebrafish   ENSDARP00000086328 19 8,194,384-8,195,385 
Zebrafish XP_001338686.1  FGENESH00000073598  15 35,474,314-35,475,153.  
Zebrafish XP_001343968.1  FGENESH00000055237  21 9,205,389-9,206,556.  
Zebrafish XP_001334570.1 ENSDARP00000009604 2 20,384,476-20,385,552.  
Zebrafish   ENSDARP00000009884 7 24,766,695-24,767,759.  
Zebrafish XP_001337554.1  FGENESH00000082569.  24 4,108,722-4,109,708.  
Zebrafish NP_001013368.1  ENSDARP00000051531 5 12,784,540-12,791,594.  
Zebrafish NP_001025368.1 GENSCAN00000041734  8 51,058,965-51,060,442.  
Zebrafish XP_001330993.1 ENSDARP00000027382 9 27,386,792-27,388,148.  
Zebrafish   ENSDARP00000022016 4 39,121,691-39,122,806.  
Zebrafish   ENSDARP00000055274 6 59,132,981-59,134,152.  
Zebrafish XP_001340906.1 GENSCAN00000038826  9 17,394,200-17,395,457.  
Zebrafish ABI99470.1 FGENESH00000070088  8 51,058,965-51,060,442.  
Zebrafish XP_001339169.1 FGENESH00000062132  3 41,370,113-41,377,705.  
Zebrafish XP_001341328.1 ENSDARP00000025567 12 33,919,188-33,922,860.  
Zebrafish XP_694953.1 ENSDARP00000050272 22 24,654,997-24,665,360.  
Zebrafish   ENSDARP00000011684 15 4,357,742-4,362,018.  
Zebrafish   ENSDARP00000076026 15 4,461,247-4,462,197 
Zebrafish   ENSDARP00000021049 15 4,413,959-4,415,307.  
Zebrafish   ENSDARP00000087292 15 4,402,047-4,403,019.  
Zebrafish   ENSDARP00000087308 15 4,374,155-4,374,790 
Zebrafish   ENSDARP00000062905 15 4,451,917-4,452,690 
Zebrafish   ENSDARP00000087287 15 4,421,132-4,423,731.  
Zebrafish   ENSDARP00000087299 15 4,387,262-4,388,179 
Zebrafish   ENSDARP00000091856 21 18,992,364-18,994,367.  
Zebrafish   ENSDARP00000092997 15 3,026,680-3,030,111.  
Zebrafish   ENSDARP00000093000 15 3,010,012-3,012,469.  
Zebrafish   ENSDARP00000057319 13 36,681,559-36,683,336.  
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Species NCBI Ensembl protein database Chromosome/Scaffold Location 
Zebrafish   ENSDARP00000088649 22 24,613,687-24,617,923.  
Zebrafish   ENSDARP00000070796 2 34,986,152-34,990,484.  
Stickleback   ENSGACP00000000942 scaffold_47 184,282-185,445.  
Stickleback   ENSGACP00000002502 scaffold_132 209,478-211,560.  
Stickleback   ENSGACP00000004999 groupVIII 1,931,956-1,933,858.  
Stickleback   ENSGACP00000007390 groupI 1,730,484-1,731,398.  
Stickleback   ENSGACP00000010855 groupI 6,840,543-6,841,996.  
Stickleback   ENSGACP00000012761 groupXV 7,895,097-7,896,633.  
Stickleback   ENSGACP00000013551 groupI 10,467,941-10,468,882.  
Stickleback   ENSGACP00000015144 groupXVII 12,409,961-12,410,890.  
Stickleback   ENSGACP00000018133 groupXI 13,421,555-13,422,436.  
Stickleback   ENSGACP00000022689 groupIV 5,767,958-5,769,001.  
Stickleback   ENSGACP00000024554 groupIV 15,741,075-15,742,240.  
Stickleback   ENSGACP00000026536 groupVII 10,390,881-10,392,102.  
Stickleback   ENSGACP00000002451 groupXVI 2,783,893-2,785,408.  
Stickleback   ENSGACP00000003378 scaffold_475 5,558-8,755.  
Stickleback   ENSGACP00000005028 groupXXI 8,709,829-8,711,970.  
Stickleback   ENSGACP00000007789 groupXIX 7,281,088-7,282,050.  
Stickleback   ENSGACP00000010882 groupI 6,917,158-6,918,464.  
Stickleback   ENSGACP00000013482 groupI 10,309,588-10,310,505.  
Stickleback   ENSGACP00000014878 groupXII 15,037,417-15,039,097.  
Stickleback   ENSGACP00000015806 groupI 14,341,623-14,343,831.  
Stickleback   ENSGACP00000018449 groupI 20,645,156-20,648,034.  
Stickleback   ENSGACP00000024549 groupIV 15,726,274-15,727,675.  
Stickleback   ENSGACP00000026938 groupVII 17,758,768-17,760,612.  
Stickleback   ENSGACP00000002454 groupXVI 2,792,172-2,793,433.  
Stickleback   ENSGACP00000005276 groupXIX 5,486,695-5,487,630.  
Stickleback   ENSGACP00000010887 groupI 6,926,441-6,928,012.  
Stickleback   ENSGACP00000013543 groupI 10,382,050-10,383,467.  
Stickleback   ENSGACP00000015138 groupXII 15,233,419-15,235,543.  
Stickleback   ENSGACP00000017795 groupIII 1,504,743-1,505,922.  
Stickleback   ENSGACP00000020237 groupIII 7,582,033-7,583,389.  
Stickleback   ENSGACP00000024551 groupIV 15,735,707-15,737,199.  
Stickleback   ENSGACP00000024559 groupIV 15,772,138-15,773,109.  
Stickleback   ENSGACP00000002511 scaffold_128 71,149-75,065.  
Stickleback   ENSGACP00000013980 groupXV 9,528,005-9,531,950.  
Stickleback   ENSGACP00000026368 groupVII 9,005,340-9,006,568.  
Stickleback   ENSGACP00000013981 groupXV 9,533,782-9,534,439.  
Stickleback   ENSGACP00000012423 groupI 9,090,447-9,091,400.  
Stickleback   ENSGACP00000016705 groupI 16,310,314-16,314,973.  




Species NCBI Ensembl protein database Chromosome/Scaffold Location 
Stickleback   ENSGACP00000013383 groupXIII 9,878,841-9,880,899.  
Stickleback   ENSGACP00000020793 groupXIV 856,996-858,082.  
Stickleback   ENSGACP00000020791 groupXIV 844,787-846,001.  
Stickleback   ENSGACP00000021482 groupIV 94,613-97,364.  
Stickleback   ENSGACP00000013380 groupXIII 9,865,275-9,867,291.  
Stickleback   ENSGACP00000020792 groupXIV 851,632-855,772.  
Stickleback   ENSGACP00000013995 groupXV 9,558,404-9,560,352.  
Stickleback   ENSGACP00000003220 groupX 2,121,801-2,122,745.  
Stickleback   ENSGACP00000003223 groupX 2,125,535-2,126,404  
Stickleback   ENSGACP00000004815 groupXXI 8,276,903-8,278,051.  
Stickleback   ENSGACP00000013986 groupXV 9,548,590-9,550,771.  
Stickleback   ENSGACP00000024507 groupIV 15,518,375-15,519,559.  
Stickleback   ENSGACP00000005053 groupXIX 5,063,430-5,064,581.  
Stickleback   ENSGACP00000013989 groupXV 9,550,633-9,554,068.  
Stickleback   ENSGACP00000013985 groupXV 9,544,137-9,545,953.  
Stickleback   ENSGACP00000013991 groupXV 9,554,340-9,556,929.  
Stickleback   ENSGACP00000010896 groupXVI 16,119,568-16,120,711.  
Stickleback   ENSGACP00000019865 groupI 24,965,025-24,966,188  
Stickleback   ENSGACP00000006492 groupI 628,832-630,104.  
Stickleback   ENSGACP00000013505 groupI 10,334,339-10,336,025.  
Stickleback   ENSGACP00000006495 groupI 638,917-644,877.  
Stickleback   ENSGACP00000021871 groupIX 4,534,658-4,536,191.  
Stickleback   ENSGACP00000013498 groupI 10,325,442-10,326,592.  
Stickleback   ENSGACP00000018857 groupIII 3,261,595-3,267,024.  
Stickleback   ENSGACP00000025060 groupVII 1,825,852-1,827,570.  
Stickleback   ENSGACP00000025070 groupVII 1,847,986-1,849,223.  
Stickleback   ENSGACP00000025072 groupVII 1,852,514-1,854,003.  
Stickleback   ENSGACP00000023536 groupIII 16,033,511-16,034,929.  
Medaka   ENSORLP00000002219 10 7,033,469-7,035,501.  
Medaka   GENSCAN00000054265  scaffold6_contig5754 3,835-4,848.  
Medaka   ENSORLP00000007398 13 12,276,545-12,277,609.  
Medaka   ENSORLP00000012926 10 23,776,892-23,778,001.  
Medaka   GENSCAN00000058831  scaffold40_contig27481 1,322-2,938.  
Medaka   ENSORLP00000013995 21 9,360,855-9,362,297.  
Medaka   GENSCAN00000093228  scaffold113_contig52046 870-2,045.  
Medaka   ENSORLP00000016967 14 24,582,440-24,585,642.  
Medaka   ENSORLP00000019532 13 32,065,644-32,068,080.  
Medaka   ENSORLP00000020401 7 25,577,394-25,579,349.  
Medaka   ENSORLP00000020821 17 25,697,062-25,699,648.  
Medaka   ENSORLP00000003758 13 6,303,968-6,307,443.  




Species NCBI Ensembl protein database Chromosome/Scaffold Location 
Medaka   ENSORLP00000010446 14 16,429,346-16,430,576.  
Medaka   ENSORLP00000012929 20 17,310,797-17,311,732.  
Medaka   GENSCAN00000039365  scaffold31_contig22747 865-1,788.  
Medaka   ENSORLP00000007471 13 12,420,330-12,422,728.  
Medaka   ENSORLP00000012907 13 19,920,732-19,923,609.  
Medaka   GENSCAN00000122403  scaffold124_contig54616 1,369-2,403.  
Medaka   ENSORLP00000012933 10 23,791,767-23,800,457.  
Medaka   ENSORLP00000012975 18 25,499,030-25,500,316.  
Medaka   GENSCAN00000118089  scaffold87_contig44759 1,479-2,606.  
Medaka   GENSCAN00000078942.  scaffold113_contig52045 1,818-3,814.  
Medaka   GENSCAN00000043172  scaffold113_contig52044 19,805-22,435.  
Medaka   ENSORLP00000019495 4 28,526,262-28,528,623.  
Medaka   GENSCAN00000094078  scaffold12_contig11312 12,331-13,296.  
Medaka   GENSCAN00000043609  scaffold265_contig80368 1,608-2,663.  
Medaka   ENSORLP00000012595 20 16,658,187-16,659,464.  
Medaka   ENSORLP00000001770 13 2,971,912-2,978,149.  
Medaka   ENSORLP00000008955 13 14,370,077-14,371,428.  
Medaka   ENSORLP00000004359 18 4,855,220-4,857,861.  
Medaka   ENSORLP00000016190 22 6,473,385-6,476,684.  
Medaka   ENSORLP00000022742 24 23,947,426-23,948,451.  
Medaka   ENSORLP00000002716 12 2,487,239-2,488,102.  
Medaka   ENSORLP00000013679 21 8,754,070-8,758,495.  
Medaka   ENSORLP00000002719 12 2,500,854-2,505,755.  
Medaka   ENSORLP00000012243 9 13,758,433-13,759,293.  
Medaka   ENSORLP00000002728 12 2,510,670-2,512,451.  
Medaka   ENSORLP00000012252 9 13,773,407-13,775,175.  
Medaka   ENSORLP00000016151 22 6,420,792-6,424,168.  
Medaka   ENSORLP00000016176 22 6,435,128-6,437,006.  
Medaka   ENSORLP00000016172 22 6,430,001-6,431,425.  
Medaka   ENSORLP00000011345 11 18,725,568-18,726,452.  
Medaka   ENSORLP00000018838 16 22,038,177-22,039,559.  
Medaka   ENSORLP00000011361 11 18,729,700-18,731,512.  
Medaka   ENSORLP00000010534 10 18,866,733-18,867,974.  
Medaka   ENSORLP00000016185 22 6,440,215-6,442,229.  
Medaka   ENSORLP00000006057 2 28,193,626-28,194,765.  
Medaka   ENSORLP00000017154 21 14,053,477-14,054,570.  
Medaka   ENSORLP00000000417 13 188,698-189,741.  
Medaka   ENSORLP00000000420 13 200,515-202,585.  
Medaka   ENSORLP00000007515 13 12,492,576-12,493,881.  
Medaka   ENSORLP00000000443 13 226,304-229,283.  
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Medaka   ENSORLP00000012908 13 19,921,273-19,924,973.  
Medaka   ENSORLP00000015583 17 18,607,766-18,617,315.  
Medaka   ENSORLP00000023635 scaffold474 194,770-197,848.  
Medaka   ENSORLP00000023642 scaffold474 207,648-208,411.  
Medaka   ENSORLP00000003694 17 3,206,894-3,208,153.  
Tetraodon CAF90112.1  GSTENP00004207001 1 9,280,563-9,281,691.  
Tetraodon CAF97358.1  GSTENP00014693001 7 9,860,643-9,862,235.  
Tetraodon CAG00913.1  GSTENP00019495001 10 9,464,265-9,465,341.  
Tetraodon CAG03809.1  GSTENP00023354001 9 10,281,976-10,282,794.  
Tetraodon CAG04290.1  GSTENP00023967001 6 3,782,208-3,782,984.  
Tetraodon   GSTENP00026760001 16 7,549,182-7,557,621.  
Tetraodon CAG10424.1 GSTENP00032057001 10 7,304,828-7,305,844.  
Tetraodon CAG14539.1 GSTENP00036486001 1 9,273,208-9,273,996.  
Tetraodon   GSTENP00004208001 1 9,295,942-9,296,815.  
Tetraodon CAF97378.1  GSTENP00014719001 16 2,404,478-2,405,551.  
Tetraodon CAG00917.1  GSTENP00019499001 10 9,527,289-9,528,587.  
Tetraodon CAG03842.1  GSCT00003286001  9 10,082,246-10,086,911.  
Tetraodon CAG04953.1 GSTENP00024817001 3 2,951,632-2,952,531.  
Tetraodon CAG07299.1  GSTENP00027920001 2 7,883,721-7,884,698.  
Tetraodon CAG12186.1 GSTENP00034382001 3 11,549,843-11,550,697.  
Tetraodon CAG14148.1 GSTENP00037810001 1 9,270,565-9,271,759.  
Tetraodon   GSTENP00009815001 Un_random 116,432,397-116,448,838  
Tetraodon   GSTENP00014725001 16 2,343,694-2,344,584.  
Tetraodon CAG03844.1 GSTENP00023395001 9 10,073,298-10,074,278.  
Tetraodon CAG05650.1 GSTENP00025746001 1_random 735,645-736,658.  
Tetraodon CAG09809.1 GSTENP00031240001 1 8,499,289-8,500,194.  
Tetraodon CAG12785.1 GSTENP00035226001 16 5,864,119-5,865,153.  
Tetraodon   GSTENP00014840001 16 1,322,744-1,323,541.  
Tetraodon CAG12733.1 GSTENP00035167001 16 6,377,491-6,378,788.  
Tetraodon   GSTENP00016932001 10 1,794,376-1,796,696.  
Tetraodon   GSTENP00035124001 Un_random 20,462,662-20,464,181.  
Tetraodon CAG02919.1 GSTENP00022162001 7 5,193,542-5,194,447.  
Tetraodon   GSTENP00028691001 12 2,774,950-2,775,867.  
Tetraodon   GSTENP00028689001 12 2,785,371-2,786,216.  
Tetraodon   GSTENP00025234001 Un_random 1,558,254-1,559,111.  
Tetraodon   GSTENP00025233001 Un_random 1,563,434-1,567,759.  
Tetraodon   GSTENP00025232001 Un_random 1,569,345-1,570,370.  
Tetraodon   GSTENG00012077001 Un_random 47,547,810-47,548,679.  
Tetraodon   GSTENP00001382001 Un_random 71,283,807-71,284,259.  
Tetraodon   GSTENP00032031001 10 7,479,304-7,483,281.  
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Tetraodon   GSTENP00022723001 Un_random 22,471,163-22,472,059.  
Tetraodon   GSTENP00022725001 Un_random 22,483,850-22,484,861.  
Tetraodon   GSTENP00001856001 Un_random 57,930,073-57,930,654.  
Tetraodon   GSTENP00003668001 Un_random 83,327,996-83,329,049.  
Tetraodon   GSTENP00008852001 Un_random 110,447,989-110,448,855.  
Tetraodon CAG04270.1 GSTENP00023936001 6 3,386,437-3,387,465.  
Tetraodon   GSTENP00029336001 1 4,022,343-4,023,317  
Tetraodon   GSTENP00027186001 3 5,654,006-5,655,053.  
Tetraodon CAF94854.1 GSTENP00011245001 Un_random 124,740,695-124,741,660.  
Tetraodon   GSTENP00014732001 16 2,302,536-2,303,345.  
Tetraodon   GSTENP00014733001 16 2,250,394-2,251,875.  
Tetraodon   GSTENP00010007001 Un_random 117,578,407-117,580,225.  
Tetraodon   GSTENP00014269001 Un_random 21,987,145-21,988,507.  
Tetraodon   GSTENP00014270001 Un_random 21,984,004-21,984,779.  
Fugu   SINFRUP00000141264 scaffold_417 98,990-100,638.  
Fugu   GENSCANSLICE00000028178  scaffold_163 452,712-453,946.  
Fugu   SINFRUP00000159316 scaffold_36 699,699-700,589.  
Fugu   SINFRUP00000179409 scaffold_19 1,437,922-1,438,965.  
Fugu   SINFRUP00000181180 scaffold_15 233,344-234,201.  
Fugu   SINFRUP00000182177 scaffold_132 490,310-491,281.  
Fugu   SINFRUP00000141960 scaffold_6 1,757,599-1,762,074.  
Fugu   SINFRUP00000151445 scaffold_173 468,694-469,756.  
Fugu   SINFRUP00000161432 scaffold_31 471,544-481,436.  
Fugu   SINFRUP00000177522 scaffold_13 126,997-128,013.  
Fugu   SINFRUP00000179625 scaffold_344 182,644-183,670.  
Fugu   SINFRUP00000181229 scaffold_10 1,241,330-1,242,346.  
Fugu   SINFRUP00000183021 scaffold_9 155,401-156,462.  
Fugu   SINFRUP00000147658 scaffold_142 539,835-540,680.  
Fugu   SINFRUP00000151908 scaffold_200 69,219-70,007.  
Fugu   SINFRUP00000165330 scaffold_173 403,846-405,443.  
Fugu   SINFRUP00000179172 scaffold_304 292,446-293,420.  
Fugu   SINFRUP00000180200 scaffold_163 433,438-434,301.  
Fugu   SINFRUP00000181470 scaffold_2435 816-10,342.  
Fugu   GENSCANSLICE00000028179  scaffold_163 457,415-459,054.  
Fugu   GENSCANSLICE00000028180  scaffold_163 461,378-462,478.  
Fugu   SINFRUP00000181476 scaffold_142 156,792-157,868.  
Fugu   SINFRUP00000178171 scaffold_304 59,403-60,263.  
Fugu   SINFRUP00000128368 scaffold_19 1,991,283-1,993,128.  
Fugu   SINFRUP00000136318 scaffold_34 596,236-601,178.  
Fugu   SINFRUP00000178764 scaffold_757 25,197-26,213.  
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Fugu   SINFRUP00000180629 scaffold_276 317,473-318,520.  
Fugu   SINFRUP00000130845 scaffold_27 140,400-141,482.  
Fugu   SINFRUP00000180210 scaffold_27 153,992-154,652.  
Fugu   SINFRUP00000130847 scaffold_27 143,059-146,762.  
Fugu   SINFRUP00000182548 scaffold_4 636,672-637,589.  
Fugu   SINFRUP00000178146 scaffold_4 647,031-647,867.  
Fugu   SINFRUP00000150183 scaffold_10 1,426,614-1,427,435.  
Fugu   SINFRUP00000150187 scaffold_10 1,431,395-1,436,521.  
Fugu   SINFRUP00000178352 scaffold_69 1,033,517-1,034,392.  
Fugu   SINFRUP00000180383 scaffold_573 73,946-74,974.  
Fugu   SINFRUP00000179870 scaffold_69 1,030,701-1,031,549.  
Fugu   SINFRUP00000180345 scaffold_35 257,783-278,516.  
Fugu   SINFRUP00000128201 scaffold_5 451,609-452,583.  
Fugu   SINFRUP00000134030 scaffold_2 2,814,874-2,816,085.  
Fugu Q6XCB2_FUGRU SINFRUP00000134141 scaffold_32 973,830-974,966.  
Fugu   SINFRUP00000138083 scaffold_9 270,357-271,854.  
Fugu   SINFRUP00000180272 scaffold_12867 1,217-2,206.  
Fugu   SINFRUP00000166034 scaffold_2529 63-482.  
Fugu   SINFRUP00000150750 scaffold_163 452,796-462,394.  
Fugu   SINFRUP00000155363 scaffold_716 35,269-39,611.  
Fugu   SINFRUP00000157228 scaffold_305 44,870-46,603.  
Fugu   SINFRUP00000170718 scaffold_305 41,858-42,676.  
Fugu   SINFRUP00000164123 scaffold_462 117,948-121,088.  
Xenopus   ENSXETP00000001218 scaffold_130 528,586-529,670.  
Xenopus   GENSCAN00000027135  scaffold_48 2,631,405-2,632,370  
Xenopus NP_989039.1  ENSXETP00000023462 scaffold_277 1,183,627-1,184,676.  
Xenopus   GENSCAN00000028902 scaffold_556 23,850-31,057.  
Xenopus   ENSXETP00000044584 scaffold_713 529,705-530,571.  
Xenopus NP_001005433.1 ENSXETP00000047746 scaffold_92 404,770-405,711.  
Xenopus   ENSXETP00000053971 scaffold_277 1,191,953-1,192,360.  
Xenopus AAI21412.1 ENSXETP00000057692 scaffold_50 3,698,831-3,699,916.  
Xenopus   ENSXETP00000006574 scaffold_55 1,602,120-1,603,226.  
Xenopus   ENSXETP00000014700 scaffold_617 169,876-181,095.  
Xenopus   ENSXETP00000023463 scaffold_277 1,281,118-1,282,056.  
Xenopus NP_001008003.1  ENSXETP00000028210 scaffold_478 164,090-165,151.  
Xenopus NP_001025633.1 ENSXETP00000050144 scaffold_117 1,200,375-1,202,006.  
Xenopus   ENSXETP00000056279 scaffold_55 1,659,665-1,704,222.  
Xenopus   ENSXETP00000056282 scaffold_55 1,612,669-1,644,858.  
Xenopus   ENSXETP00000022341 scaffold_258 869,068-870,102.  
Xenopus   ENSXETP00000024345 scaffold_390 661,523-663,920.  
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Xenopus   ENSXETP00000044651 scaffold_713 576,320-577,297.  
Xenopus   ENSXETP00000053350 scaffold_258 688,808-689,779.  
Xenopus   GENSCAN00000027075  scaffold_48 2,648,100-2,649,110.  
Xenopus   GENSCAN00000027116  scaffold_48 2,640,321-2,641,340.  
Xenopus AAI21581.1  ENSXETP00000036876 scaffold_409 480,582-481,628.  
Xenopus   ENSXETP00000056732 scaffold_49 2,548,951-2,551,091.  
Xenopus NP_001004810.1 ENSXETP00000036888 scaffold_409 472,761-473,795.  
Xenopus   GENSCAN00000056936  scaffold_258 721,618-722,670.  
Xenopus   ENSXETP00000005770 scaffold_65 2,996,388-2,997,427.  
Xenopus   ENSXETP00000029577 scaffold_94 297,797-301,454.  
Xenopus   ENSXETP00000053195 scaffold_64 3,012,135-3,072,453.  
Xenopus   ENSXETP00000007235 scaffold_113 2,609,822-2,623,507.  
Xenopus   ENSXETP00000007247 scaffold_113 2,540,085-2,543,035.  
Xenopus   ENSXETP00000037231 scaffold_679 513,772-514,803.  
Xenopus   ENSXETP00000055469 scaffold_351 404,849-446,304.  
Xenopus   ENSXETP00000055467 scaffold_351 561,182-586,791.  
Xenopus   ENSXETP00000055471 scaffold_351 404,825-446,304.  
Xenopus   ENSXETP00000055468 scaffold_351 445,507-561,179.  
Xenopus   ENSXETP00000030483 scaffold_185 1,199,131-1,200,124.  
Xenopus   ENSXETP00000035060 scaffold_284 533,931-534,971.  
Xenopus   ENSXETP00000053184 scaffold_518 693,316-694,374  
Xenopus NP_001025605.1  GENSCAN00000014227  scaffold_15 2,143,102-2,157,196.  
Xenopus   ENSXETP00000039815 scaffold_258 95,871-96,999.  
Xenopus   ENSXETP00000054789 scaffold_35 815,812-816,315  
Xenopus   ENSXETP00000044545 scaffold_713 241,894-266,458.  
Xenopus   ENSXETP00000044559 scaffold_713 279,493-298,555.  
Xenopus   ENSXETP00000044560 scaffold_713 310,839-311,852.  
Xenopus   ENSXETP00000054000 scaffold_1836 17,997-20,696.  
Xenopus   FGENESH00000006348  scaffold_689 106,939-107,796.  
Xenopus   GENSCAN00000076358.  scaffold_702 381,863-384,168.  
Xenopus   ENSXETP00000017831 scaffold_279.  976,995-982,811.  
Xenopus   GENSCAN00000062538 scaffold_408 117,883-118,941.  
Xenopus   GENSCAN00000053024 scaffold_31 3,188,819-3,211,089.  
Xenopus   GENSCAN00000051641 scaffold_224 1,372,416-1,373,420.  
Xenopus   ENSXETP00000044537 scaffold_713 241,363-242,793.  
Xenopus   ENSXETP00000026874 scaffold_2462.  143-703.  
Xenopus   ENSXETP00000039948 scaffold_258.  689,790-722,625.  
Xenopus   ENSXETP00000037521 scaffold_556.  30,089-50,629.  
Xenopus   ENSXETP00000023462 scaffold_277.  1,183,627-1,184,676.  
Xenopus   ENSXETP00000037509 scaffold_91.  2,737,577-2,757,895.  
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Human   ENSP00000171757 X  78,102,674-78,103,693.  
Human   ENSP00000276077 X  78,313,161-78,314,162.  
Human   ENSP00000309771 11 72,685,212-72,686,198.  
Human   ENSP00000323872 19 10,083,398-10,086,414.  
Human   ENSP00000344353 13 47,883,526-47,884,560.  
Human   ENSP00000362398 X  77,897,023-77,898,135.  
Human   ENSP00000365888 13 96,437,001-96,438,014.  
Human   ENSP00000258380 2 231,482,962-231,483,921.  
Human   ENSP00000301974 1 28,349,091-28,350,119.  
Human   ENSP00000310305 11 72,622,853-72,623,986.  
Human   ENSP00000327875 12 6,599,557-6,600,675.  
Human   ENSP00000355156 3 153,080,371-153,082,026.  
Human   ENSP00000362401 X  77,414,886-77,415,899.  
Human   ENSP00000272644 2 128,124,057-128,125,799.  
Human   ENSP00000282018 13 48,178,955-48,179,995.  
Human   ENSP00000304767 3 154,036,262-154,037,383.  
Human   ENSP00000322731 2 241,218,043-241,218,972.  
Human   ENSP00000335289 X  69,395,102-69,396,199.  
Human   ENSP00000362397 X  78,227,089-78,228,101.  
Human   ENSP00000365596 13 98,745,315-98,746,400.  
Human   ENSP00000372385 3 160,041,482-160,042,567.  
Human   ENSP00000238699 14 90,770,050-90,771,177.  
Human   ENSP00000328818 14 104,588,376-104,592,802.  
Human   ENSP00000267549 14 87,546,945-87,547,958.  
Human   ENSP00000319744 19 50,785,876-50,786,964.  
Human   ENSP00000248076 19 16,861,001-16,862,432.  
Human   ENSP00000321326 5 76,047,889-76,065,084.  
Human   ENSP00000296641 5 75,949,163-75,954,811.  
Human   ENSP00000296677 5 76,150,764-76,165,382.  
Human   ENSP00000370697 X  1,544,372-1,545,451.  
Human   ENSP00000307713 14 95,773,198-95,777,594.  
Human   ENSP00000246538 19 40,554,102-40,555,142.  
Human   ENSP00000246549 19 40,632,457-40,633,449.  
Human   ENSP00000328230 19 40,541,633-40,542,673.  
Human   ENSP00000216629 14 95,799,773-95,800,834  
Human   ENSP00000273430 3 149,941,513-149,942,592.  
Human   ENSP00000360973 X  115,217,562-115,218,653.  
Human   ENSP00000367376 X  41,439,831-41,440,976.  
Human   ENSP00000307259 3 152,538,295-152,539,323.  
Human   ENSP00000308479 3 152,398,904-152,399,863.  
Human   ENSP00000308361 3 152,413,778-152,414,794.  
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Human   ENSP00000260843 3 152,494,647-152,500,578.  
Human   ENSP00000320376 3 152,528,469-152,529,470  
Human   ENSP00000307445 14 23,854,698-23,855,756.  
Lamprey   GENSCAN00000158257 Contig Contig28082.1 1,432-4,885.  
Lamprey   GENSCAN00000095337 Contig1237.5 6,089-8,552.  
Lamprey   GENSCAN00000077202 Contig1237.3 3,423-8,820.  
Lamprey   GENSCAN00000136436 Contig1155.4 2,435-5,646.  
Lamprey   GENSCAN00000084877 Contig23485.2 498-5,191.  
Lamprey   GENSCAN00000157564 Contig20098.3 63-1,514.  
Lamprey   GENSCAN00000121221 Contig39423.2 848-1,907.  
Lamprey   GENSCAN00000156679 Contig12084.1 4,224-5,243.  
Lamprey   GENSCAN00000037718 Contig12724.3 2,531-3,526.  
Lamprey   GENSCAN00000044642 Contig4826.2 752-6,901.  
Lamprey   GENSCAN00000063763 Contig40178.2 683-1,795.  
Lamprey   GENSCAN00000009189 Contig51058.2 818-1,990.  
Lamprey   GENSCAN00000146267 Contig20197.3 2,582-3,661.  
Lamprey   GENSCAN00000119553 Contig17584.5 2,999-4,018.  
Lamprey   GENSCAN00000128815 Contig23839.5 651-1,382.  
Lamprey   GENSCAN00000020987 Contig4102.4 8,105-9,136.  
Lamprey   GENSCAN00000047780 Contig16137.2 3,192-5,482.  
Lamprey   GENSCAN00000036578 Contig6216.2 8,939-10,219.  
Lamprey   GENSCAN00000094439 Contig5757.3 6,568-7,674.  
Lamprey   GENSCAN00000007934 Contig97.6 1,329-2,297.  
Lamprey   GENSCAN00000036479 Contig1237.4 44-528.  
Lamprey   GENSCAN00000111041 Contig80603.2 994-1,854.  
Lamprey   GENSCAN00000036489 Contig15747.3 2,752-3,891.  
Lamprey   GENSCAN00000011025 Contig28634.4 2,445-3,218.  
Lamprey   GENSCAN00000042303 Contig1593.6 6,057-11,008.  
Lamprey   GENSCAN00000014373 Contig905.7 12,484-13,392.  
Lamprey   GENSCAN00000053656 Contig6884.5 1,754-3,814.  
Lamprey   GENSCAN00000005865 Contig1100.6 1,049-2,300.  
Lamprey   GENSCAN00000119531 Contig7476.7 2,776-3,969.  
Lamprey   GENSCAN00000035238 Contig26957.2 197-1,066.  
Lamprey   GENSCAN00000118369 Contig9287.1 5,108-6,220.  
Lamprey   GENSCAN00000157983 Contig571.8 2,975-6,823.  
Lamprey   GENSCAN00000025544 Contig25590.1 314-1,366.  
Lamprey   GENSCAN00000095106 Contig20976.4 1,912-2,926.  
Lamprey   GENSCAN00000046309 Contig1126.1 507-1,202.  
Lamprey   GENSCAN00000035678 Contig80717.2 20-689.  
Lamprey   GENSCAN00000135946 Contig76467.2 524-1,061.  
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Lamprey   GENSCAN00000027224 Contig905.5 3,391-4,299.  
Lamprey   GENSCAN00000067925 Contig32517.2 472-1,793.  
Lamprey   GENSCAN00000127875 Contig47802.2 24-972.  
Lamprey   GENSCAN00000041420 Contig8376.4 504-1,742.  
Lamprey   GENSCAN00000074896 Contig83438.1 570-1,520.  
Lamprey   GENSCAN00000136806 Contig7537.2 432-7,942.  
Lamprey   GENSCAN00000091571 Contig11380.5 17-910.  
Lamprey   GENSCAN00000043020 Contig7879.4 6,931-8,169.  
Lamprey   GENSCAN00000065760 Contig1968.8 198-1,721.  
Lamprey   GENSCAN00000151939 Contig1968.7 2,616-3,830.  
Lamprey   GENSCAN00000015235   551-1,678.  
Lamprey   GENSCAN00000097352 Contig1968.9 3,650-6,836.  
Lamprey   GENSCAN00000089907 Contig3453.6 1,109-4,266.  
Lamprey   GENSCAN00000036448 Contig1593.1 1,687-2,637.  
Lamprey   GENSCAN00000054943 Contig17736.3 3,495-4,436.  
Lamprey   GENSCAN00000014065 Contig2020.1 19,415-20,392.  
Elephant shark AAVX01000008     1099306860870 
Elephant shark AAVX01005288     1099306865997 
Elephant shark AAVX01011008     1099306871677 
Elephant shark AAVX01016502     1099306877170 
Elephant shark AAVX01025604     1099306886267 
Elephant shark AAVX01026588     1099306887249 
Elephant shark AAVX01028503     1099306889164 
Elephant shark AAVX01051690     1099306912159 
Elephant shark AAVX01056054     1099306916507 
Elephant shark AAVX01056829     1099306917278 
Elephant shark AAVX01059132     1099306919568 
Elephant shark AAVX01062489     1099306922907 
Elephant shark AAVX01064747     1099306925154 
Elephant shark AAVX01065781     1099306926180 
Elephant shark AAVX01072944     1099306933185 
Elephant shark AAVX01074580     1099306933605 
Elephant shark AAVX01096862     1099306955612 
Elephant shark AAVX01103357     1099306962107 
Elephant shark AAVX01109705     1099306968455 
Elephant shark AAVX01123176     1099306981927 
Elephant shark AAVX01124620     1099306983371 
Elephant shark AAVX01130182     1099306988934 
Elephant shark AAVX01132629     1099306991381 
Elephant shark AAVX01153499     1099306385629 
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Elephant shark AAVX01206512     1099306528802 
Elephant shark AAVX01207006     1099306530160 
Elephant shark AAVX01234747     1099306605966 
Elephant shark AAVX01247055     1099306639703 
Elephant shark AAVX01292903     1099306763742 
Elephant shark AAVX01326185     1099306851145 
Elephant shark AAVX01373377     1236908_1 
Elephant shark AAVX01395879     1098890040701 
Elephant shark AAVX01444803     1098980708334 
Elephant shark AAVX01500497     1098882303600 






























D.   Expression of FFAR2c in brain and pharyngeal arches. 
 
 
Analysis of FFAR2c  expression in 5dpf larval by whole mount in situ hybridization. Panel (A-C), 
whole mount and (D-G) transverse sections after hybridization. A) Lateral view shows 
expression in the brain and pharyngeal arches; (B) Dorsal view shows expression in the brain; 
(C) Ventral view shows expression in Merkel’s cartilage and branchial arches; In the brain, the 
expression is distributed from telencephalon to medulla oblongata in rhombencephalon (D-F); 
Expression is also detected in otic vesicle (F). Abbreviations: BA: branchial arches; MC: 
Merkel’s cartilage; MO: medulla oblongata; OV: otic vesicle; TeO: optic tectum; Th: thalamus; 







E.   Schematic drawing of pharyngeal arches of zebrafish 
 
 
A) Schematic drawing of cartilage in ventral view of 5 dpf larval adapted from Piotrowski et al., 
2003. B) Lateral view of pharyngeal branches in zebrafish adapted from Holzschuh et al., 2005. 
Abbreviations: Cb 1-5, ceratobranchial cartilages; ch, ceratohyal cartilage; gAD, dorsal anterior 
lateral line; gAV, ventral anterior lateral line; gP, posterior lateral line; gV, trigeminal; gVII, facial 
(geniculate), gVIII, auditory; gIX, glossopharyngeal (petrosal); gX, vagal (nodose); hm, 
hyomandibula; m, Meckel’s cartilage of mandibular arch; n, notochord; oa, occipital arch; pq, 
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